C |
Age hay fever, rhinitis or eczema diagnosed |
77,452 |
CTGLAB |
31427789 |
2019 |
ENSG00000197728 |
RPS26 |
rs1131017 |
0.1645 |
1.0000 |
0.1645 |
0.1645 |
1 |
|
C |
Age hay fever, rhinitis or eczema diagnosed |
72,232 |
Nealelab |
Nealelab |
2018 |
ENSG00000149485 |
FADS1 |
rs174561 |
0.1090 |
0.4881 |
0.0532 |
0.1064 |
1 |
|
C |
Age hay fever, rhinitis or eczema diagnosed |
72,232 |
Nealelab |
Nealelab |
2018 |
ENSG00000204282 |
TNRC6C-AS1 |
rs16970672 |
0.1120 |
0.3666 |
0.0410 |
0.0458 |
3 |
|
C |
Age hay fever, rhinitis or eczema diagnosed |
77,452 |
CTGLAB |
31427789 |
2019 |
ENSG00000139531 |
SUOX |
rs1081975 |
0.0931 |
0.3802 |
0.0354 |
0.0673 |
1 |
|
C |
Age hay fever, rhinitis or eczema diagnosed |
72,232 |
Nealelab |
Nealelab |
2018 |
ENSG00000221968 |
FADS3 |
rs28456 |
0.0522 |
0.6417 |
0.0335 |
0.0655 |
1 |
|
C |
Age hay fever, rhinitis or eczema diagnosed |
77,452 |
CTGLAB |
31427789 |
2019 |
ENSG00000065361 |
ERBB3 |
rs2271194 |
0.0275 |
0.9166 |
0.0252 |
0.0270 |
1 |
Oligodendrocytes (Habib), oligodendrocytes (Darmanis) |
C |
Age high blood pressure diagnosed |
87,024 |
Nealelab |
Nealelab |
2018 |
ENSG00000149485 |
FADS1 |
rs174561 |
0.1091 |
0.4881 |
0.0533 |
0.1065 |
1 |
|
C |
Age high blood pressure diagnosed |
87,024 |
Nealelab |
Nealelab |
2018 |
ENSG00000204282 |
TNRC6C-AS1 |
rs16970672 |
0.1120 |
0.3666 |
0.0411 |
0.0458 |
3 |
|
C |
Age high blood pressure diagnosed |
87,024 |
Nealelab |
Nealelab |
2018 |
ENSG00000221968 |
FADS3 |
rs28456 |
0.0522 |
0.6417 |
0.0335 |
0.0655 |
1 |
|
C |
Age started wearing glasses or contact lenses |
332,074 |
CTGLAB |
31427789 |
2019 |
ENSG00000108654 |
DDX5 |
rs1991401 |
0.8727 |
1.0000 |
0.8727 |
0.8727 |
1 |
NSC (Habib) |
C |
Age started wearing glasses or contact lenses |
332,074 |
CTGLAB |
31427789 |
2019 |
ENSG00000258890 |
CEP95 |
rs1991401 |
0.8727 |
0.9718 |
0.8481 |
0.8481 |
1 |
|
C |
Age started wearing glasses or contact lenses |
310,992 |
Nealelab |
Nealelab |
2018 |
ENSG00000135437 |
RDH5 |
rs3138142 |
0.8833 |
0.8249 |
0.7286 |
0.7286 |
1 |
|
C |
Age started wearing glasses or contact lenses |
310,992 |
Nealelab |
Nealelab |
2018 |
ENSG00000135441 |
BLOC1S1 |
rs3138142 |
0.8833 |
0.4401 |
0.3887 |
0.3887 |
1 |
|
C |
Age started wearing glasses or contact lenses |
332,074 |
CTGLAB |
31427789 |
2019 |
ENSG00000104903 |
LYL1 |
rs11555274 |
0.2004 |
0.4153 |
0.0832 |
0.1879 |
1 |
|
C |
Age started wearing glasses or contact lenses |
332,074 |
CTGLAB |
31427789 |
2019 |
ENSG00000204282 |
TNRC6C-AS1 |
rs16970672 |
0.1462 |
0.3666 |
0.0536 |
0.0606 |
3 |
|
C |
Age started wearing glasses or contact lenses |
332,074 |
CTGLAB |
31427789 |
2019 |
ENSG00000115380 |
EFEMP1 |
rs78857879 |
0.0195 |
0.9968 |
0.0194 |
0.0194 |
2 |
NSC (Habib), astrocytes (Darmanis) |
C |
Allergic disease (asthma, hay FEVer or eczema) |
360,838 |
Ferreira MA |
29083406 |
2017 |
ENSG00000117586 |
TNFSF4 |
rs11811788 |
0.5018 |
0.4786 |
0.2401 |
0.4380 |
1 |
|
C |
Allergic disease (asthma, hay FEVer or eczema) |
360,838 |
Ferreira MA |
29083406 |
2017 |
ENSG00000197457 |
STMN3 |
rs2236506 |
0.0956 |
0.5576 |
0.0533 |
0.0556 |
1 |
Glutamatergic (Lake) |
C |
Allergic disease (asthma, hay FEVer or eczema) |
360,838 |
Ferreira MA |
29083406 |
2017 |
ENSG00000258366 |
RTEL1 |
rs2236506 |
0.0956 |
0.1088 |
0.0104 |
0.0159 |
1 |
|
C |
Alzheimer's disease or family history of alzheimer's disease |
314,278 |
Marioni RE |
29777097 |
2018 |
ENSG00000159640 |
ACE |
rs6504163 |
0.2402 |
0.5669 |
0.1362 |
0.1636 |
1 |
|
C |
Alzheimer's disease or family history of alzheimer's disease |
314,278 |
Marioni RE |
29777097 |
2018 |
ENSG00000168077 |
SCARA3 |
rs7982 |
0.3741 |
0.1044 |
0.0391 |
0.0452 |
2 |
astrocytes (Darmanis) |
C |
Alzheimer's disease or family history of alzheimer's disease |
314,278 |
Marioni RE |
29777097 |
2018 |
ENSG00000178226 |
PRSS36 |
rs78924645 |
0.0141 |
1.0000 |
0.0141 |
0.0141 |
1 |
|
C |
Alzheimer's disease stage 1 |
54,162 |
IGAP |
24162737 |
2013 |
ENSG00000203710 |
CR1 |
rs679515 |
0.1785 |
0.9912 |
0.1769 |
0.1769 |
1 |
|
C |
Alzheimer's disease stage 1 |
54,162 |
IGAP |
24162737 |
2013 |
ENSG00000168077 |
SCARA3 |
rs7982 |
0.2094 |
0.1044 |
0.0219 |
0.0240 |
2 |
astrocytes (Darmanis) |
C |
Alzheimer's disease stage 1 and 2 |
74,046 |
IGAP |
24162737 |
2013 |
ENSG00000168077 |
SCARA3 |
rs7982 |
0.2930 |
0.1044 |
0.0306 |
0.0363 |
2 |
astrocytes (Darmanis) |
C |
Amyotrophic lateral sclerosis |
36,052 |
van Rheenen W |
27455348 |
2017 |
ENSG00000004139 |
SARM1 |
rs739439 |
0.4002 |
0.7014 |
0.2807 |
0.4367 |
1 |
|
C |
Amyotrophic lateral sclerosis |
80,610 |
Nicolas A |
29566793 |
2018 |
ENSG00000211445 |
GPX3 |
rs4958872 |
0.1308 |
0.9972 |
0.1304 |
0.1304 |
1 |
|
C |
Amyotrophic lateral sclerosis |
80,610 |
Nicolas A |
29566793 |
2018 |
ENSG00000135677 |
GNS |
rs12229321 |
0.0406 |
0.8962 |
0.0364 |
0.0364 |
2 |
|
C |
Asthma |
26,475 |
Moffatt MF |
20860503 |
2010 |
ENSG00000073605 |
GSDMB |
rs2290400 |
0.5003 |
0.1705 |
0.0853 |
0.1173 |
2 |
|
C |
Asthma |
26,475 |
Moffatt MF |
20860503 |
2010 |
ENSG00000172057 |
ORMDL3 |
rs2290400 |
0.5003 |
0.0316 |
0.0158 |
0.0158 |
1 |
|
C |
Asthma |
127,669 |
Demenais F |
29273806 |
2018 |
ENSG00000134987 |
WDR36 |
rs10455025 |
0.7731 |
0.0192 |
0.0148 |
0.0192 |
3 |
|
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000128591 |
FLNC |
rs55985730 |
0.9750 |
1.0000 |
0.9750 |
0.9750 |
1 |
|
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000105974 |
CAV1 |
rs1997571 |
0.2930 |
0.8117 |
0.2379 |
0.3088 |
1 |
|
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000116132 |
PRRX1 |
rs651386 |
0.4186 |
0.2517 |
0.1054 |
0.1054 |
2 |
|
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000078674 |
PCM1 |
rs478420 |
0.0400 |
1.0000 |
0.0400 |
0.0400 |
1 |
OPC_Cer (Lake), Microglia (Lake) |
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000087338 |
GMCL1 |
rs6747542 |
0.3141 |
0.1170 |
0.0368 |
0.1197 |
1 |
|
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000010803 |
SCMH1 |
rs2885697 |
0.9869 |
0.0259 |
0.0256 |
0.0256 |
1 |
|
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000105971 |
CAV2 |
rs1997571 |
0.2930 |
0.0809 |
0.0237 |
0.0478 |
1 |
endothelial (Darmanis) |
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000166833 |
NAV2 |
rs2625322 |
0.0237 |
0.9968 |
0.0237 |
0.0237 |
1 |
GABAergic (Lake), Astrocytes (Lake), Ast_Cer (Lake), OPC (Lake), OPC_Cer (Lake), Astrocytes (Habib) |
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000114054 |
PCCB |
rs10935184 |
0.0179 |
0.8921 |
0.0160 |
0.0161 |
1 |
|
C |
Atrial fibrillation |
1,030,836 |
Nielsen JB |
30061737 |
2018 |
ENSG00000233223 |
AC113189.5 |
rs9899183 |
0.1530 |
0.0742 |
0.0113 |
0.0215 |
2 |
|
C |
Baseline positive affect factor score |
381 |
Hart AB |
22952603 |
2012 |
ENSG00000145545 |
SRD5A1 |
rs531241 |
0.4050 |
0.0620 |
0.0251 |
0.0251 |
1 |
|
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000100418 |
DESI1 |
rs55906059 |
0.3789 |
0.7296 |
0.2764 |
0.3859 |
4 |
|
C |
Birth weight |
205,475 |
Nealelab |
Nealelab |
2018 |
ENSG00000165804 |
ZNF219 |
rs12889267 |
0.6312 |
0.3644 |
0.2300 |
0.2680 |
1 |
|
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000198911 |
SREBF2 |
rs41311445 |
0.6106 |
0.1756 |
0.1072 |
0.1957 |
1 |
|
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000029534 |
ANK1 |
rs515071 |
0.2935 |
0.1385 |
0.0406 |
0.0792 |
1 |
GABAergic (Lake) |
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000077454 |
LRCH4 |
rs909152 |
0.7833 |
0.0518 |
0.0405 |
0.0425 |
2 |
|
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000197157 |
SND1 |
rs73234873 |
0.0432 |
0.5982 |
0.0259 |
0.0410 |
1 |
|
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000132128 |
LRRC41 |
rs55752916 |
0.2461 |
0.1031 |
0.0254 |
0.0464 |
1 |
|
C |
Birth weight |
205,475 |
Nealelab |
Nealelab |
2018 |
ENSG00000163933 |
RFT1 |
rs1864367 |
0.0246 |
0.9999 |
0.0246 |
0.0246 |
1 |
|
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000134308 |
YWHAQ |
rs10210919 |
0.0336 |
0.3826 |
0.0129 |
0.0277 |
3 |
|
C |
Birth weight |
205,475 |
Nealelab |
Nealelab |
2018 |
ENSG00000170291 |
ELP5 |
rs2074219 |
0.0431 |
0.2829 |
0.0122 |
0.0397 |
1 |
|
C |
Birth weight |
219,088 |
CTGLAB |
31427789 |
2019 |
ENSG00000072778 |
ACADVL |
rs446994 |
0.0332 |
0.3258 |
0.0108 |
0.0250 |
1 |
Astrocytes (Habib) |
C |
Birth weight eur |
134,323 |
Horikoshi M |
27680694 |
2016 |
ENSG00000100418 |
DESI1 |
rs41311445 |
0.6628 |
0.1794 |
0.1189 |
0.1559 |
4 |
|
C |
Birth weight eur |
134,323 |
Horikoshi M |
27680694 |
2016 |
ENSG00000198911 |
SREBF2 |
rs41311445 |
0.6628 |
0.1756 |
0.1164 |
0.1282 |
1 |
|
C |
Birth weight eur |
134,323 |
Horikoshi M |
27680694 |
2016 |
ENSG00000160685 |
ZBTB7B |
rs905938 |
0.1922 |
0.2860 |
0.0550 |
0.0740 |
1 |
|
C |
Birth weight eur |
134,323 |
Horikoshi M |
27680694 |
2016 |
ENSG00000198945 |
L3MBTL3 |
rs7740107 |
0.0369 |
1.0000 |
0.0369 |
0.0369 |
1 |
|
C |
Birth weight eur |
134,323 |
Horikoshi M |
27680694 |
2016 |
ENSG00000164161 |
HHIP |
rs2131354 |
0.4071 |
0.0818 |
0.0333 |
0.0468 |
1 |
Oligodendrocytes (Habib) |
C |
Birth weight eur |
134,323 |
Horikoshi M |
27680694 |
2016 |
ENSG00000163354 |
DCST2 |
rs74520550 |
0.0672 |
0.4545 |
0.0305 |
0.0381 |
2 |
|
C |
Birth weight of first child (female) |
165,872 |
CTGLAB |
31427789 |
2019 |
ENSG00000164161 |
HHIP |
rs2131354 |
0.7422 |
0.0818 |
0.0607 |
0.0632 |
1 |
Oligodendrocytes (Habib) |
C |
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma |
385,822 |
CTGLAB |
31427789 |
2019 |
ENSG00000131507 |
NDFIP1 |
rs1821263 |
0.0342 |
0.6549 |
0.0224 |
0.0245 |
1 |
Glutamatergic (Lake), GABAergic (Lake) |
C |
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma |
385,822 |
CTGLAB |
31427789 |
2019 |
ENSG00000158864 |
NDUFS2 |
rs1136224 |
0.0144 |
1.0000 |
0.0144 |
0.0144 |
1 |
Glutamatergic (Lake) |
C |
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema |
385,822 |
CTGLAB |
31427789 |
2019 |
ENSG00000176681 |
LRRC37A |
rs4792851 |
0.0799 |
0.4275 |
0.0341 |
0.0454 |
7 |
|
C |
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema |
385,822 |
CTGLAB |
31427789 |
2019 |
ENSG00000197457 |
STMN3 |
rs2236506 |
0.0271 |
0.5576 |
0.0151 |
0.0311 |
1 |
Glutamatergic (Lake) |
C |
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema |
385,822 |
CTGLAB |
31427789 |
2019 |
ENSG00000157837 |
SPPL3 |
rs1718188 |
0.0166 |
0.8176 |
0.0135 |
0.0145 |
1 |
|
C |
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema |
385,822 |
CTGLAB |
31427789 |
2019 |
ENSG00000160685 |
ZBTB7B |
rs905938 |
0.0384 |
0.2860 |
0.0110 |
0.0145 |
1 |
|
C |
Breast cancer |
139,274 |
Michailidou K |
29059683 |
2017 |
ENSG00000050327 |
ARHGEF5 |
rs720475 |
0.3032 |
1.0000 |
0.3032 |
0.3032 |
1 |
|
C |
Breast cancer |
139,274 |
Michailidou K |
29059683 |
2017 |
ENSG00000118655 |
DCLRE1B |
rs11552449 |
0.1140 |
0.3504 |
0.0400 |
0.1120 |
1 |
|
C |
Breast cancer |
139,274 |
Michailidou K |
29059683 |
2017 |
ENSG00000164649 |
CDCA7L |
rs56333627 |
0.0319 |
0.8546 |
0.0273 |
0.0295 |
5 |
|
C |
Breast cancer |
139,274 |
Michailidou K |
29059683 |
2017 |
ENSG00000150867 |
PIP4K2A |
rs1326339 |
0.0229 |
0.9999 |
0.0229 |
0.0229 |
2 |
Oligodendrocytes (Lake), Oligodendrocytes (Habib) |
C |
Breast cancer |
139,274 |
Michailidou K |
29059683 |
2017 |
ENSG00000143013 |
LMO4 |
rs3008455 |
0.1329 |
0.0956 |
0.0127 |
0.0149 |
1 |
Glutamatergic (Lake), Glutamatergic (Habib) |
C |
Breast cancer (GEE, adjusted for age and BMI) |
723 |
Larson MG |
17903305 |
2007 |
ENSG00000151743 |
AMN1 |
rs1003460 |
1.0000 |
0.0364 |
0.0364 |
0.0364 |
2 |
|
C |
Breast cancer (GEE, adjusted for age and BMI) |
723 |
Larson MG |
17903305 |
2007 |
ENSG00000135838 |
NPL |
rs10494559 |
0.7521 |
0.0240 |
0.0180 |
0.0180 |
1 |
|
C |
Breast cancer (GEE, adjusted for age and BMI) |
723 |
Larson MG |
17903305 |
2007 |
ENSG00000197763 |
TXNRD3 |
rs939479 |
0.7365 |
0.0163 |
0.0120 |
0.0120 |
1 |
|
C |
Breast cancer (GEE, adjusted for age) |
723 |
Larson MG |
17903305 |
2007 |
ENSG00000151743 |
AMN1 |
rs1003460 |
1.0000 |
0.0364 |
0.0364 |
0.0364 |
2 |
|
C |
Breast cancer (GEE, adjusted for age) |
723 |
Larson MG |
17903305 |
2007 |
ENSG00000135838 |
NPL |
rs10494559 |
0.7872 |
0.0240 |
0.0189 |
0.0189 |
1 |
|
C |
C15-C26 Malignant neoplasms of digestive organs |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000166923 |
GREM1 |
rs2293582 |
0.1633 |
0.2806 |
0.0458 |
0.0683 |
2 |
|
C |
C43-C44 Melanoma and other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000138061 |
CYP1B1 |
rs6734590 |
0.1522 |
0.8460 |
0.1287 |
0.1529 |
1 |
endothelial (Darmanis) |
C |
C43-C44 Melanoma and other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000168071 |
CCDC88B |
rs479552 |
0.0406 |
0.9962 |
0.0405 |
0.0405 |
1 |
|
C |
C43-C44 Melanoma and other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000026297 |
RNASET2 |
rs2247315 |
0.0604 |
0.5411 |
0.0327 |
0.0528 |
1 |
Microglia (Habib) |
C |
C43-C44 Melanoma and other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000064012 |
CASP8 |
rs6714430 |
0.1270 |
0.1652 |
0.0210 |
0.0706 |
1 |
|
C |
C43-C44 Melanoma and other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000118655 |
DCLRE1B |
rs11552449 |
0.0475 |
0.3504 |
0.0166 |
0.0352 |
1 |
|
C |
C44 Other and unspecified malignant neoplasm of skin |
300,791 |
CTGLAB |
31427789 |
2019 |
ENSG00000064012 |
CASP8 |
rs6714430 |
0.1061 |
0.1652 |
0.0175 |
0.0664 |
1 |
|
C |
C44 Other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000138061 |
CYP1B1 |
rs6734590 |
0.0782 |
0.8460 |
0.0661 |
0.0953 |
1 |
endothelial (Darmanis) |
C |
C44 Other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000168071 |
CCDC88B |
rs479552 |
0.0396 |
0.9962 |
0.0395 |
0.0395 |
1 |
|
C |
C44 Other malignant neoplasms of skin |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000026297 |
RNASET2 |
rs2247315 |
0.0556 |
0.5411 |
0.0301 |
0.0513 |
1 |
Microglia (Habib) |
C |
C44 Other malignant neoplasms of skin |
361,194 |
Nealelab |
Nealelab |
2018 |
ENSG00000064012 |
CASP8 |
rs2080303 |
0.0791 |
0.3568 |
0.0282 |
0.0788 |
1 |
|
C |
C60-C63 Malignant neoplasms of male genital organs |
206,770 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115486 |
GGCX |
rs6743030 |
0.0299 |
0.3605 |
0.0108 |
0.0331 |
1 |
|
C |
C61 Malignant neoplasm of prostate |
206,770 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115486 |
GGCX |
rs6743030 |
0.0317 |
0.3605 |
0.0114 |
0.0339 |
1 |
|
C |
Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS |
60,655 |
CTGLAB |
31427789 |
2019 |
ENSG00000064012 |
CASP8 |
rs6714430 |
0.1217 |
0.1652 |
0.0201 |
0.0635 |
1 |
|
C |
Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin |
54,696 |
CTGLAB |
31427789 |
2019 |
ENSG00000101464 |
PIGU |
rs62209647 |
0.8450 |
0.0127 |
0.0107 |
0.0111 |
1 |
|
C |
Chest pain or discomfort |
382,525 |
CTGLAB |
31427789 |
2019 |
ENSG00000164116 |
GUCY1A3 |
rs72689147 |
0.1385 |
0.3048 |
0.0422 |
0.1139 |
1 |
|
C |
Childhood sunburn occasions |
289,412 |
CTGLAB |
31427789 |
2019 |
ENSG00000101464 |
PIGU |
rs62209647 |
1.0000 |
0.0127 |
0.0127 |
0.0127 |
1 |
|
C |
Chronic kidney disease |
117,165 |
Pattaro C |
26831199 |
2016 |
ENSG00000213347 |
MXD3 |
rs4976685 |
0.0369 |
0.9990 |
0.0369 |
0.0369 |
2 |
|
C |
Colorectal cancer |
33,870 |
Tanikawa C |
29471430 |
2018 |
ENSG00000124191 |
TOX2 |
rs6065668 |
0.0706 |
0.2375 |
0.0168 |
0.0272 |
1 |
GABAergic (Lake) |
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000101000 |
PROCR |
rs867186 |
0.7792 |
0.3779 |
0.2945 |
0.2945 |
1 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000119917 |
IFIT3 |
rs2266008 |
1.0000 |
0.2389 |
0.2389 |
0.2389 |
1 |
|
C |
Coronary artery disease |
84,264 |
Schunkert H |
21378990 |
2011 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.2401 |
0.5530 |
0.1328 |
0.1328 |
1 |
|
C |
Coronary artery disease |
148,715 |
Nelson CP |
28714975 |
2017 |
ENSG00000068745 |
IP6K2 |
rs3172494 |
0.0939 |
0.9907 |
0.0931 |
0.0931 |
2 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000203760 |
CENPW |
rs1591805 |
0.2233 |
0.2760 |
0.0616 |
0.0712 |
1 |
|
C |
Coronary artery disease |
148,715 |
Nelson CP |
28714975 |
2017 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0749 |
0.8171 |
0.0612 |
0.0665 |
1 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000164116 |
GUCY1A3 |
rs7692387 |
0.9232 |
0.0624 |
0.0576 |
0.0655 |
1 |
|
C |
Coronary artery disease |
84,264 |
Schunkert H |
21378990 |
2011 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.0552 |
0.8959 |
0.0494 |
0.0494 |
1 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000257017 |
HP |
rs2000999 |
0.0485 |
0.9945 |
0.0483 |
0.0483 |
1 |
|
C |
Coronary artery disease |
148,715 |
Nelson CP |
28714975 |
2017 |
ENSG00000107798 |
LIPA |
rs2246942 |
0.8050 |
0.0464 |
0.0374 |
0.0374 |
5 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000136378 |
ADAMTS7 |
rs7173743 |
0.9849 |
0.0351 |
0.0346 |
0.0346 |
3 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000119718 |
EIF2B2 |
rs175016 |
0.0338 |
0.9708 |
0.0328 |
0.0328 |
1 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000164535 |
DAGLB |
rs13235365 |
0.0325 |
0.9998 |
0.0325 |
0.0325 |
1 |
Mic (Darmanis) |
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000140830 |
TXNL4B |
rs2000999 |
0.0485 |
0.6674 |
0.0324 |
0.0324 |
1 |
|
C |
Coronary artery disease |
148,715 |
Nelson CP |
28714975 |
2017 |
ENSG00000162407 |
PPAP2B |
rs56170783 |
0.1273 |
0.2376 |
0.0303 |
0.1001 |
1 |
Astrocytes (Habib) |
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000225697 |
SLC26A6 |
rs7617773 |
0.7036 |
0.0400 |
0.0281 |
0.0326 |
2 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000115486 |
GGCX |
rs6743030 |
0.0697 |
0.3605 |
0.0251 |
0.0555 |
1 |
|
C |
Coronary artery disease |
148,715 |
Nelson CP |
28714975 |
2017 |
ENSG00000214435 |
AS3MT |
rs12414777 |
0.0197 |
0.9999 |
0.0196 |
0.0196 |
2 |
|
C |
Coronary artery disease |
148,715 |
Nelson CP |
28714975 |
2017 |
ENSG00000166275 |
C10orf32 |
rs12414777 |
0.0197 |
0.8472 |
0.0166 |
0.0170 |
3 |
|
C |
Coronary artery disease |
296,525 |
van der Harst P |
29212778 |
2017 |
ENSG00000182511 |
FES |
rs10744971 |
0.0486 |
0.2214 |
0.0108 |
0.0288 |
1 |
|
C |
Coronary artery disease |
547,261 |
van der Harst P |
29212778 |
2017 |
ENSG00000141298 |
SSH2 |
rs7220401 |
0.2095 |
0.0512 |
0.0107 |
0.0210 |
1 |
|
C |
Coronary artery disease |
296,525 |
van der Harst P |
29212778 |
2017 |
ENSG00000272750 |
RP11-378J18.8 |
rs17465637 |
0.0826 |
0.1258 |
0.0104 |
0.0493 |
1 |
|
C |
Coronary artery disease / myocardial infarction |
120,575 |
Webb TR |
28209224 |
2017 |
ENSG00000272750 |
RP11-378J18.8 |
rs17465637 |
1.0000 |
0.1258 |
0.1258 |
0.1258 |
1 |
|
C |
Coronary artery disease / myocardial infarction |
120,575 |
Webb TR |
28209224 |
2017 |
ENSG00000107798 |
LIPA |
rs2246942 |
0.8293 |
0.0464 |
0.0385 |
0.0385 |
5 |
|
C |
Crohn's disease |
20,883 |
Liu JZ |
26192919 |
2015 |
ENSG00000101017 |
CD40 |
rs1883832 |
0.1453 |
0.3191 |
0.0464 |
0.0764 |
1 |
|
C |
Crohn's disease |
20,883 |
Liu JZ |
26192919 |
2015 |
ENSG00000165684 |
SNAPC4 |
rs4077515 |
0.1359 |
0.2028 |
0.0276 |
0.0482 |
3 |
|
C |
Crohn's disease |
20,883 |
Liu JZ |
26192919 |
2015 |
ENSG00000261662 |
RP5-1042I8.7 |
rs2641348 |
0.8618 |
0.0208 |
0.0179 |
0.0197 |
1 |
|
C |
Crohn's disease |
20,883 |
Liu JZ |
26192919 |
2015 |
ENSG00000261338 |
RP11-378A13.1 |
rs13419763 |
0.0116 |
1.0000 |
0.0116 |
0.0116 |
1 |
|
C |
Crohn's disease |
20,883 |
Liu JZ |
26192919 |
2015 |
ENSG00000187796 |
CARD9 |
rs11793497 |
0.4301 |
0.0250 |
0.0108 |
0.0155 |
2 |
|
C |
Crohn's disease |
20,883 |
Liu JZ |
26192919 |
2015 |
ENSG00000235316 |
DUSP8P5 |
rs2688607 |
0.1016 |
0.1038 |
0.0106 |
0.0106 |
1 |
|
C |
D12 Benign neoplasm of colon, rectum, anus and anal canal |
361,194 |
Nealelab |
Nealelab |
2018 |
ENSG00000166923 |
GREM1 |
rs2293581 |
0.2000 |
0.1520 |
0.0304 |
0.0544 |
2 |
|
C |
D86 Sarcoidosis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000189129 |
PLAC9 |
rs2784770 |
0.0146 |
0.7245 |
0.0106 |
0.0131 |
1 |
|
C |
Daytime dozing / sleeping (narcolepsy) |
384,879 |
CTGLAB |
31427789 |
2019 |
ENSG00000134369 |
NAV1 |
rs623025 |
0.0486 |
0.9986 |
0.0485 |
0.0485 |
1 |
Ast_Cer (Lake), OPC (Lake), OPC (Habib) |
C |
Daytime dozing / sleeping (narcolepsy) |
384,879 |
CTGLAB |
31427789 |
2019 |
ENSG00000145194 |
ECE2 |
rs56172794 |
0.0163 |
0.9930 |
0.0162 |
0.0162 |
1 |
|
C |
Doctor diagnosed hayfever or allergic rhinitis |
97,640 |
CTGLAB |
31427789 |
2019 |
ENSG00000056558 |
TRAF1 |
rs1930786 |
0.0137 |
0.9516 |
0.0131 |
0.0131 |
1 |
|
C |
E00-E07 Disorders of thyroid gland |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169169 |
CPT1C |
rs1075453 |
0.0689 |
0.9929 |
0.0684 |
0.0684 |
1 |
|
C |
E00-E07 Disorders of thyroid gland |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000026297 |
RNASET2 |
rs2757039 |
0.0540 |
0.3117 |
0.0168 |
0.0363 |
1 |
Microglia (Habib) |
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000197728 |
RPS26 |
rs1131017 |
0.1187 |
1.0000 |
0.1187 |
0.1187 |
1 |
|
C |
E03 Other hypothyroidism |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000139531 |
SUOX |
rs773114 |
0.1667 |
0.6068 |
0.1011 |
0.1177 |
1 |
|
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169169 |
CPT1C |
rs1075453 |
0.0889 |
0.9929 |
0.0883 |
0.0883 |
1 |
|
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000065361 |
ERBB3 |
rs2271194 |
0.0263 |
0.9166 |
0.0241 |
0.0265 |
1 |
Oligodendrocytes (Habib), oligodendrocytes (Darmanis) |
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000198917 |
C9orf114 |
rs13297295 |
0.4649 |
0.0379 |
0.0176 |
0.0314 |
1 |
|
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000173295 |
FAM86B3P |
rs2945250 |
0.0566 |
0.2714 |
0.0153 |
0.0559 |
1 |
|
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000160447 |
PKN3 |
rs13289095 |
0.0337 |
0.3477 |
0.0117 |
0.0239 |
1 |
|
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000026297 |
RNASET2 |
rs2757039 |
0.0370 |
0.3117 |
0.0115 |
0.0156 |
1 |
Microglia (Habib) |
C |
E03 Other hypothyroidism |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134825 |
TMEM258 |
rs174538 |
0.0108 |
0.9941 |
0.0107 |
0.0107 |
1 |
|
C |
E11 Non-insulin-dependent diabetes mellitus |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000153814 |
JAZF1 |
rs1635851 |
0.2398 |
0.6728 |
0.1613 |
0.1721 |
1 |
|
C |
E11 Non-insulin-dependent diabetes mellitus |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000130584 |
ZBTB46 |
rs6011155 |
0.1407 |
0.9524 |
0.1340 |
0.1340 |
1 |
|
C |
E11 Non-insulin-dependent diabetes mellitus |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000029534 |
ANK1 |
rs6989203 |
0.0765 |
0.2067 |
0.0158 |
0.0744 |
1 |
GABAergic (Lake) |
C |
E11 Type 2 diabetes mellitus |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000130584 |
ZBTB46 |
rs6011155 |
0.1078 |
0.9524 |
0.1026 |
0.1026 |
1 |
|
C |
E11 Type 2 diabetes mellitus |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000153814 |
JAZF1 |
rs1635851 |
0.0444 |
0.6728 |
0.0299 |
0.0318 |
1 |
|
C |
E11 Type 2 diabetes mellitus |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000029534 |
ANK1 |
rs6989203 |
0.0734 |
0.2067 |
0.0152 |
0.0732 |
1 |
GABAergic (Lake) |
C |
E70-E90 Metabolic disorders |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.3262 |
0.5530 |
0.1804 |
0.3041 |
1 |
|
C |
E70-E90 Metabolic disorders |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000140830 |
TXNL4B |
rs3794695 |
0.1894 |
0.2763 |
0.0523 |
0.1000 |
1 |
|
C |
E70-E90 Metabolic disorders |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000257017 |
HP |
rs2000999 |
0.0486 |
0.9945 |
0.0483 |
0.0483 |
1 |
|
C |
E78 Disorders of lipoprotein metabolism and other lipidaemias |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000165029 |
ABCA1 |
rs2244278 |
0.3509 |
0.6505 |
0.2283 |
0.3711 |
1 |
|
C |
E78 Disorders of lipoprotein metabolism and other lipidaemias |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.4063 |
0.5530 |
0.2247 |
0.3634 |
1 |
|
C |
E78 Disorders of lipoprotein metabolism and other lipidaemias |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000140830 |
TXNL4B |
rs3794695 |
0.1954 |
0.2763 |
0.0540 |
0.0783 |
1 |
|
C |
E78 Disorders of lipoprotein metabolism and other lipidaemias |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000257017 |
HP |
rs2000999 |
0.0274 |
0.9945 |
0.0272 |
0.0272 |
1 |
|
C |
E78 Disorders of lipoprotein metabolism and other lipidaemias |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000007944 |
MYLIP |
rs2480 |
0.0203 |
0.9875 |
0.0201 |
0.0201 |
1 |
|
C |
E78 Disorders of lipoprotein metabolism and other lipidemias |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.2784 |
0.5530 |
0.1540 |
0.2178 |
1 |
|
C |
E78 Disorders of lipoprotein metabolism and other lipidemias |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000140830 |
TXNL4B |
rs3794695 |
0.2500 |
0.2763 |
0.0691 |
0.0785 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000250959 |
GLUD1P3 |
rs7904489 |
0.5170 |
0.9496 |
0.4910 |
0.4910 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000176293 |
ZNF135 |
rs1469087 |
0.2824 |
1.0000 |
0.2824 |
0.2824 |
2 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000160685 |
ZBTB7B |
rs76798800 |
0.8233 |
0.2539 |
0.2091 |
0.2581 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000197586 |
ENTPD6 |
rs4815394 |
0.9558 |
0.1870 |
0.1787 |
0.1787 |
5 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000251474 |
RPL32P3 |
rs2811430 |
0.0570 |
0.8346 |
0.0476 |
0.0479 |
2 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000125970 |
RALY |
rs4911405 |
0.9609 |
0.0471 |
0.0453 |
0.0453 |
1 |
|
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000138061 |
CYP1B1 |
rs1800440 |
0.9997 |
0.0371 |
0.0371 |
0.0371 |
1 |
endothelial (Darmanis) |
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163945 |
UVSSA |
rs111391498 |
0.5645 |
0.0633 |
0.0358 |
0.0358 |
1 |
|
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000140941 |
MAP1LC3B |
rs1050863 |
0.1109 |
0.2548 |
0.0283 |
0.0756 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000139370 |
SLC15A4 |
rs56290671 |
0.2693 |
0.1036 |
0.0279 |
0.0772 |
1 |
|
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000181915 |
ADO |
rs10995311 |
0.1560 |
0.1718 |
0.0268 |
0.0268 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000143437 |
ARNT |
rs1136774 |
0.1203 |
0.1804 |
0.0217 |
0.0854 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000164050 |
PLXNB1 |
rs188450461 |
0.6576 |
0.0328 |
0.0216 |
0.0216 |
2 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000170889 |
RPS9 |
rs2304523 |
0.0189 |
1.0000 |
0.0189 |
0.0189 |
2 |
END (Habib) |
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000177225 |
PDDC1 |
rs11606152 |
0.1478 |
0.1272 |
0.0188 |
0.0593 |
2 |
|
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000100316 |
RPL3 |
rs470082 |
0.0195 |
0.9463 |
0.0184 |
0.0194 |
2 |
Glutamatergic (Lake), END (Habib) |
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000270210 |
RP11-373D23.3 |
rs7589485 |
0.0234 |
0.6803 |
0.0159 |
0.0271 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000129465 |
RIPK3 |
rs3212250 |
0.0534 |
0.2918 |
0.0156 |
0.0442 |
1 |
|
C |
Ease of skin tanning |
378,364 |
CTGLAB |
31427789 |
2019 |
ENSG00000107551 |
RASSF4 |
rs41306544 |
0.0273 |
0.4949 |
0.0135 |
0.0256 |
1 |
|
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000066230 |
SLC9A3 |
rs78091523 |
0.1058 |
0.1022 |
0.0108 |
0.0648 |
2 |
|
C |
Ease of skin tanning |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000225138 |
CTD-2228K2.7 |
rs78091523 |
0.1058 |
0.1017 |
0.0108 |
0.0658 |
2 |
|
C |
Family history of Alzheimer's disease |
314,278 |
Marioni RE |
29777097 |
2018 |
ENSG00000203710 |
CR1 |
rs679515 |
0.1729 |
0.9912 |
0.1714 |
0.1714 |
1 |
|
C |
G50-G59 Nerve, nerve root and plexus disorders |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000259134 |
LINC00924 |
rs8039277 |
0.0496 |
1.0000 |
0.0496 |
0.0496 |
1 |
|
C |
G56 Mononeuropathies of upper limb |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115380 |
EFEMP1 |
rs2009262 |
0.0429 |
0.4686 |
0.0201 |
0.0403 |
3 |
NSC (Habib), astrocytes (Darmanis) |
C |
H40 Glaucoma |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000058866 |
DGKG |
rs56233426 |
0.9971 |
0.1463 |
0.1458 |
0.1458 |
1 |
Glutamatergic (Lake), Gran (Lake), GABAergic (Lake), Astrocytes (Lake), Ast_Cer (Lake), OPC (Lake), exDG (Habib) |
C |
H40 Glaucoma |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000143183 |
TMCO1 |
rs2790049 |
0.1299 |
0.0772 |
0.0100 |
0.0438 |
2 |
|
C |
H40-H42 Glaucoma |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000058866 |
DGKG |
rs56233426 |
0.9972 |
0.1463 |
0.1459 |
0.1459 |
1 |
Glutamatergic (Lake), Gran (Lake), GABAergic (Lake), Astrocytes (Lake), Ast_Cer (Lake), OPC (Lake), exDG (Habib) |
C |
H40-H42 Glaucoma |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000143183 |
TMCO1 |
rs2790049 |
0.1306 |
0.0772 |
0.0101 |
0.0439 |
2 |
|
C |
H90-H95 Other disorders of ear |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000175029 |
CTBP2 |
rs11598549 |
0.1537 |
0.1008 |
0.0155 |
0.0294 |
1 |
|
C |
Hearing difficulty/problems |
370,713 |
CTGLAB |
31427789 |
2019 |
ENSG00000072778 |
ACADVL |
rs35224044 |
0.0643 |
0.3258 |
0.0210 |
0.0385 |
1 |
Astrocytes (Habib) |
C |
Hearing difficulty/problems |
370,713 |
CTGLAB |
31427789 |
2019 |
ENSG00000100106 |
TRIOBP |
rs739138 |
0.1513 |
0.1212 |
0.0183 |
0.0183 |
2 |
|
C |
Hearing difficulty/problems |
370,713 |
CTGLAB |
31427789 |
2019 |
ENSG00000175826 |
CTDNEP1 |
rs222851 |
0.0535 |
0.2775 |
0.0148 |
0.0288 |
1 |
|
C |
Hearing difficulty/problems with background noise |
378,722 |
CTGLAB |
31427789 |
2019 |
ENSG00000117280 |
RAB7L1 |
rs708723 |
0.1187 |
0.4655 |
0.0553 |
0.1182 |
1 |
|
C |
Hearing difficulty/problems with background noise |
378,722 |
CTGLAB |
31427789 |
2019 |
ENSG00000076944 |
STXBP2 |
rs794076 |
0.3349 |
0.1059 |
0.0355 |
0.0971 |
1 |
Mic (Darmanis) |
C |
Hearing difficulty/problems with background noise |
378,722 |
CTGLAB |
31427789 |
2019 |
ENSG00000229833 |
PET100 |
rs794085 |
0.0562 |
0.4607 |
0.0259 |
0.0579 |
1 |
|
C |
Hearing difficulty/problems with background noise |
378,722 |
CTGLAB |
31427789 |
2019 |
ENSG00000159335 |
PTMS |
rs11064373 |
0.9088 |
0.0165 |
0.0150 |
0.0150 |
1 |
END (Habib) |
C |
Height in females |
73,137 |
Randall JC |
23754948 |
2013 |
ENSG00000117122 |
MFAP2 |
rs2284746 |
0.9771 |
0.3899 |
0.3809 |
0.3809 |
1 |
fetal_replicating (Darmanis) |
C |
Height in females |
73,137 |
Randall JC |
23754948 |
2013 |
ENSG00000248890 |
HHIP-AS1 |
rs1812175 |
0.7098 |
0.2054 |
0.1458 |
0.2291 |
1 |
|
C |
Height in females |
73,137 |
Randall JC |
23754948 |
2013 |
ENSG00000198860 |
TSEN15 |
rs2274432 |
0.2476 |
0.2963 |
0.0734 |
0.0734 |
1 |
|
C |
Height in females |
73,137 |
Randall JC |
23754948 |
2013 |
ENSG00000101391 |
CDK5RAP1 |
rs293713 |
0.1817 |
0.1681 |
0.0306 |
0.0510 |
1 |
|
C |
Height in females |
73,137 |
Randall JC |
23754948 |
2013 |
ENSG00000007312 |
CD79B |
rs2070776 |
0.3665 |
0.0797 |
0.0292 |
0.0464 |
1 |
endothelial (Darmanis) |
C |
Height in females |
73,137 |
Randall JC |
23754948 |
2013 |
ENSG00000081692 |
JMJD4 |
rs3088389 |
0.0425 |
0.3609 |
0.0153 |
0.0401 |
1 |
|
C |
Height in females |
73,137 |
Randall JC |
23754948 |
2013 |
ENSG00000224165 |
DNAJC27-AS1 |
rs754536 |
0.0351 |
0.3037 |
0.0107 |
0.0343 |
1 |
|
C |
High grade serous ovarian cancer |
53,978 |
Phelan M |
28346442 |
2017 |
ENSG00000164695 |
CHMP4C |
rs78724141 |
0.1462 |
0.4534 |
0.0663 |
0.1110 |
1 |
|
C |
High grade serous ovarian cancer |
53,978 |
Phelan M |
28346442 |
2017 |
ENSG00000166965 |
RCCD1 |
rs3826033 |
0.0146 |
1.0000 |
0.0146 |
0.0146 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000196196 |
HRCT1 |
rs76452347 |
1.0000 |
1.0000 |
1.0000 |
1.0000 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000235387 |
LINC00961 |
rs76452347 |
1.0000 |
0.8780 |
0.8780 |
0.8780 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000165916 |
PSMC3 |
rs11039216 |
0.9337 |
0.5963 |
0.5568 |
0.5568 |
2 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000181856 |
SLC2A4 |
rs5418 |
0.4678 |
0.4042 |
0.1891 |
0.3510 |
1 |
astrocytes (Darmanis) |
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000138792 |
ENPEP |
rs33966350 |
0.0821 |
0.9685 |
0.0795 |
0.0795 |
2 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000130517 |
PGPEP1 |
rs35343344 |
0.1551 |
0.4364 |
0.0677 |
0.1503 |
2 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000129911 |
KLF16 |
rs12977787 |
0.0692 |
0.9587 |
0.0663 |
0.0663 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000159640 |
ACE |
rs4292 |
0.0984 |
0.3611 |
0.0355 |
0.0487 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000164116 |
GUCY1A3 |
rs72689147 |
0.1131 |
0.3048 |
0.0345 |
0.1081 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000262877 |
RP11-1055B8.4 |
rs113458760 |
0.0221 |
0.7017 |
0.0155 |
0.0210 |
2 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000138193 |
PLCE1 |
rs12263737 |
0.1457 |
0.0915 |
0.0133 |
0.0277 |
2 |
GABAergic (Lake), NSC (Habib) |
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115825 |
PRKD3 |
rs2540977 |
0.0659 |
0.1755 |
0.0116 |
0.0380 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000167528 |
ZNF641 |
rs9788082 |
0.0164 |
0.6533 |
0.0107 |
0.0181 |
1 |
|
C |
I10-I15 Hypertensive diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000103510 |
KAT8 |
rs4527034 |
0.0140 |
0.7391 |
0.0104 |
0.0122 |
1 |
|
C |
I20 Angina pectoris |
361,194 |
Nealelab |
Nealelab |
2018 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.3993 |
0.8959 |
0.3577 |
0.3614 |
1 |
|
C |
I20 Angina pectoris |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.2192 |
0.5530 |
0.1212 |
0.2032 |
1 |
|
C |
I20 Angina pectoris |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115486 |
GGCX |
rs10179195 |
0.0412 |
0.3605 |
0.0149 |
0.0405 |
1 |
|
C |
I20-I25 Ischaemic heart diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.2359 |
0.8959 |
0.2113 |
0.2154 |
1 |
|
C |
I20-I25 Ischaemic heart diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.1262 |
0.5530 |
0.0698 |
0.1307 |
1 |
|
C |
I20-I25 Ischaemic heart diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0350 |
0.8171 |
0.0286 |
0.0350 |
1 |
|
C |
I20-I25 Ischaemic heart diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115486 |
GGCX |
rs10179195 |
0.0655 |
0.3605 |
0.0236 |
0.0592 |
1 |
|
C |
I20-I25 Ischaemic heart diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000260244 |
RP11-588K22.2 |
rs11731886 |
0.1191 |
0.1963 |
0.0234 |
0.0240 |
1 |
|
C |
I20-I25 Ischaemic heart diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000164116 |
GUCY1A3 |
rs72689147 |
0.0594 |
0.3048 |
0.0181 |
0.0548 |
1 |
|
C |
I20-I25 Ischaemic heart diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000162407 |
PPAP2B |
rs72664335 |
0.1005 |
0.1281 |
0.0129 |
0.0509 |
1 |
Astrocytes (Habib) |
C |
I21 Acute myocardial infarction |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.2054 |
0.8959 |
0.1840 |
0.1868 |
1 |
|
C |
I21 Acute myocardial infarction |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.0999 |
0.5530 |
0.0552 |
0.0961 |
1 |
|
C |
I21 Acute myocardial infarction |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0136 |
0.8171 |
0.0111 |
0.0125 |
1 |
|
C |
I25 Chronic ischaemic heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.1241 |
0.5530 |
0.0686 |
0.1349 |
1 |
|
C |
I25 Chronic ischaemic heart disease |
361,194 |
Nealelab |
Nealelab |
2018 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.0685 |
0.8959 |
0.0614 |
0.0626 |
1 |
|
C |
I25 Chronic ischaemic heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0466 |
0.8171 |
0.0381 |
0.0464 |
1 |
|
C |
I25 Chronic ischaemic heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000260244 |
RP11-588K22.2 |
rs11731886 |
0.1612 |
0.1963 |
0.0317 |
0.0329 |
1 |
|
C |
I25 Chronic ischaemic heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115486 |
GGCX |
rs6743030 |
0.0777 |
0.3605 |
0.0280 |
0.0691 |
1 |
|
C |
I25 Chronic ischaemic heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000162407 |
PPAP2B |
rs72664335 |
0.1082 |
0.1281 |
0.0139 |
0.0535 |
1 |
Astrocytes (Habib) |
C |
I25 Chronic ischemic heart disease |
300,791 |
CTGLAB |
31427789 |
2019 |
ENSG00000171700 |
RGS19 |
rs8121509 |
0.1405 |
0.9922 |
0.1394 |
0.1394 |
1 |
|
C |
I25 Chronic ischemic heart disease |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.1147 |
0.8959 |
0.1027 |
0.1078 |
1 |
|
C |
I25 Chronic ischemic heart disease |
300,791 |
CTGLAB |
31427789 |
2019 |
ENSG00000171703 |
TCEA2 |
rs4408777 |
0.1038 |
0.6228 |
0.0647 |
0.1244 |
1 |
|
C |
I25 Chronic ischemic heart disease |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000134222 |
PSRC1 |
rs646776 |
0.0970 |
0.4418 |
0.0428 |
0.0729 |
1 |
|
C |
I25 Chronic ischemic heart disease |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000115486 |
GGCX |
rs10179195 |
0.0737 |
0.3605 |
0.0266 |
0.0663 |
1 |
|
C |
I25 Chronic ischemic heart disease |
300,791 |
CTGLAB |
31427789 |
2019 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0222 |
0.8171 |
0.0182 |
0.0209 |
1 |
|
C |
I25 Chronic ischemic heart disease |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000162407 |
PPAP2B |
rs72664335 |
0.1044 |
0.1281 |
0.0134 |
0.0536 |
1 |
Astrocytes (Habib) |
C |
I25 Chronic ischemic heart disease |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000182511 |
FES |
rs1029420 |
0.0280 |
0.4587 |
0.0128 |
0.0177 |
1 |
|
C |
I30-I52 Other forms of heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000116132 |
PRRX1 |
rs56250774 |
0.0914 |
1.0000 |
0.0914 |
0.0914 |
1 |
|
C |
I30-I52 Other forms of heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000120370 |
GORAB |
rs56250774 |
0.0914 |
0.4359 |
0.0399 |
0.0475 |
3 |
|
C |
I30-I52 Other forms of heart disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000105974 |
CAV1 |
rs1997571 |
0.0194 |
0.8117 |
0.0157 |
0.0224 |
1 |
|
C |
I48 Atrial fibrillation and flutter |
361,194 |
Nealelab |
Nealelab |
2018 |
ENSG00000105974 |
CAV1 |
rs1997571 |
0.1935 |
0.8117 |
0.1571 |
0.2173 |
1 |
|
C |
I48 Atrial fibrillation and flutter |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000116132 |
PRRX1 |
rs56250774 |
0.1328 |
1.0000 |
0.1328 |
0.1328 |
1 |
|
C |
I48 Atrial fibrillation and flutter |
244,890 |
CTGLAB |
31427789 |
2019 |
ENSG00000120370 |
GORAB |
rs7544273 |
0.1413 |
0.4957 |
0.0701 |
0.1279 |
3 |
|
C |
I48 Atrial fibrillation and flutter |
361,194 |
Nealelab |
Nealelab |
2018 |
ENSG00000105971 |
CAV2 |
rs11773845 |
0.4850 |
0.0346 |
0.0168 |
0.0362 |
1 |
endothelial (Darmanis) |
C |
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000245937 |
CTC-228N24.3 |
rs2250127 |
0.1643 |
0.2163 |
0.0355 |
0.1089 |
1 |
|
C |
I83 Varicose veins of lower extremities |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000245937 |
CTC-228N24.3 |
rs2250127 |
0.2982 |
0.2163 |
0.0645 |
0.1629 |
1 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000013725 |
CD6 |
rs11230563 |
0.9412 |
0.4815 |
0.4532 |
0.4532 |
1 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000107882 |
SUFU |
rs2274351 |
0.7966 |
0.1590 |
0.1267 |
0.1281 |
1 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000088305 |
DNMT3B |
rs6058869 |
0.8146 |
0.1040 |
0.0848 |
0.0848 |
1 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000101017 |
CD40 |
rs1883832 |
0.1104 |
0.3191 |
0.0352 |
0.0647 |
1 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000165684 |
SNAPC4 |
rs10870077 |
0.3522 |
0.0469 |
0.0165 |
0.0403 |
3 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000160766 |
GBAP1 |
rs28445596 |
0.0867 |
0.1547 |
0.0134 |
0.0253 |
1 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000162572 |
SCNN1D |
rs12103 |
0.6881 |
0.0170 |
0.0117 |
0.0121 |
2 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000231889 |
TRAF3IP2-AS1 |
rs13210247 |
0.0206 |
0.5527 |
0.0114 |
0.0114 |
1 |
GABAergic (Lake), OPC_Cer (Lake) |
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000116288 |
PARK7 |
rs12727642 |
0.0746 |
0.1444 |
0.0108 |
0.0122 |
1 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000187796 |
CARD9 |
rs11793497 |
0.4197 |
0.0250 |
0.0105 |
0.0161 |
2 |
|
C |
Inflammatory bowel disease |
34,652 |
Liu JZ |
26192919 |
2015 |
ENSG00000261338 |
RP11-378A13.1 |
rs13419763 |
0.0101 |
1.0000 |
0.0101 |
0.0101 |
1 |
|
C |
Insomnia |
386,533 |
Philip R |
BioRxiv_214973 |
2017 |
ENSG00000186834 |
HEXIM1 |
rs9894577 |
0.2352 |
0.0509 |
0.0120 |
0.0203 |
1 |
|
C |
Invasive ovarian cancer |
63,347 |
Phelan M |
28346442 |
2017 |
ENSG00000164695 |
CHMP4C |
rs78724141 |
0.1547 |
0.4534 |
0.0701 |
0.1199 |
1 |
|
C |
J33 Nasal polyp |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000143412 |
ANXA9 |
rs6684154 |
0.6254 |
1.0000 |
0.6254 |
0.6254 |
1 |
|
C |
J34 Other disorders of nose and nasal sinuses |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000187608 |
ISG15 |
rs72896218 |
0.0457 |
0.8552 |
0.0391 |
0.0391 |
1 |
END (Habib), endothelial (Darmanis) |
C |
J40-J47 Chronic lower respiratory diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000168743 |
NPNT |
rs34712979 |
0.9206 |
0.8019 |
0.7383 |
0.7474 |
1 |
|
C |
J40-J47 Chronic lower respiratory diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000197728 |
RPS26 |
rs1131017 |
0.0152 |
1.0000 |
0.0152 |
0.0152 |
1 |
|
C |
J40-J47 Chronic lower respiratory diseases |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000221968 |
FADS3 |
rs28456 |
0.0182 |
0.6417 |
0.0117 |
0.0145 |
1 |
|
C |
K31 Other diseases of stomach and duodenum |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169231 |
THBS3 |
rs760077 |
0.6065 |
1.0000 |
0.6065 |
0.6065 |
1 |
astrocytes (Darmanis) |
C |
K31 Other diseases of stomach and duodenum |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000185499 |
MUC1 |
rs760077 |
0.6065 |
0.2323 |
0.1409 |
0.1409 |
1 |
|
C |
K42 Umbilical hernia |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115380 |
EFEMP1 |
rs6747490 |
0.1665 |
0.1503 |
0.0250 |
0.0306 |
1 |
NSC (Habib), astrocytes (Darmanis) |
C |
K50 Crohn's disease [regional enteritis] |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000167468 |
GPX4 |
rs4807542 |
0.3809 |
0.9844 |
0.3750 |
0.3750 |
1 |
|
C |
K51 Ulcerative colitis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000143365 |
RORC |
rs10888436 |
0.3998 |
0.1086 |
0.0434 |
0.0562 |
1 |
|
C |
K51 Ulcerative colitis |
361,194 |
Nealelab |
Nealelab |
2018 |
ENSG00000124120 |
TTPAL |
rs4812835 |
0.2012 |
0.1095 |
0.0220 |
0.0220 |
2 |
|
C |
K55-K64 Other diseases of intestines |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000166923 |
GREM1 |
rs79207432 |
0.6547 |
0.4119 |
0.2697 |
0.3043 |
2 |
|
C |
K59 Other functional intestinal disorders |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000184792 |
OSBP2 |
rs55694472 |
0.2470 |
0.1551 |
0.0383 |
0.0987 |
2 |
Glutamatergic (Lake), Purk1 (Lake), Purk2 (Lake) |
C |
K63 Other diseases of intestine |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000166923 |
GREM1 |
rs79207432 |
0.1930 |
0.4119 |
0.0795 |
0.1447 |
2 |
|
C |
K80 Cholelithiasis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000105677 |
TMEM147 |
rs7599 |
0.3384 |
0.2462 |
0.0833 |
0.1267 |
1 |
|
C |
K80 Cholelithiasis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000236144 |
AD000090.2 |
rs7599 |
0.3384 |
0.0385 |
0.0130 |
0.0567 |
2 |
|
C |
K80-K87 Disorders of gallbladder, biliary tract and pancreas |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000170604 |
IRF2BP1 |
rs3745926 |
0.1020 |
0.1393 |
0.0142 |
0.0257 |
1 |
|
C |
L00-L08 Infections of the skin and subcutaneous tissue |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000245937 |
CTC-228N24.3 |
rs6860245 |
0.0880 |
0.3009 |
0.0265 |
0.0931 |
1 |
|
C |
L03 Cellulitis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000245937 |
CTC-228N24.3 |
rs6888037 |
0.1038 |
0.3259 |
0.0338 |
0.1157 |
1 |
|
C |
Low grade serous ovarian cancer |
41,953 |
Phelan M |
28346442 |
2017 |
ENSG00000169330 |
KIAA1024 |
rs57310278 |
0.0496 |
0.5903 |
0.0293 |
0.0459 |
1 |
|
C |
M05-M14 Inflammatory polyarthropathies |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000171044 |
XKR6 |
rs10090444 |
0.1177 |
0.7025 |
0.0827 |
0.0866 |
1 |
Glutamatergic (Lake), Gran (Lake), Purk1 (Lake), Purk2 (Lake) |
C |
M13 Other arthritis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000171044 |
XKR6 |
rs10090444 |
0.0843 |
0.7025 |
0.0592 |
0.0650 |
1 |
Glutamatergic (Lake), Gran (Lake), Purk1 (Lake), Purk2 (Lake) |
C |
M15-M19 Arthrosis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000198756 |
COLGALT2 |
rs7539021 |
0.2929 |
1.0000 |
0.2929 |
0.2929 |
1 |
|
C |
M15-M19 Arthrosis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163235 |
TGFA |
rs3771501 |
0.0800 |
0.4617 |
0.0369 |
0.0834 |
1 |
|
C |
M16 Coxarthrosis [arthrosis of hip] |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163235 |
TGFA |
rs2862851 |
0.0824 |
0.2942 |
0.0242 |
0.0571 |
1 |
|
C |
M16 Coxarthrosis [arthrosis of hip] |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163935 |
SFMBT1 |
rs34230854 |
0.0333 |
0.5745 |
0.0191 |
0.0285 |
1 |
|
C |
M16 Coxarthrosis [arthrosis of hip] |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000013810 |
TACC3 |
rs11732213 |
0.1505 |
0.1095 |
0.0165 |
0.0263 |
2 |
|
C |
M16 Coxarthrosis [arthrosis of hip] |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000198756 |
COLGALT2 |
rs7539021 |
0.0120 |
1.0000 |
0.0120 |
0.0120 |
1 |
|
C |
M16 Osteoarthritis of hip |
300,791 |
CTGLAB |
31427789 |
2019 |
ENSG00000163235 |
TGFA |
rs2862851 |
0.1374 |
0.2942 |
0.0404 |
0.0943 |
1 |
|
C |
M16 Osteoarthritis of hip |
300,791 |
CTGLAB |
31427789 |
2019 |
ENSG00000163935 |
SFMBT1 |
rs34230854 |
0.0557 |
0.5745 |
0.0320 |
0.0500 |
1 |
|
C |
M20-M25 Other joint disorders |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000101019 |
UQCC1 |
rs62210593 |
0.2094 |
0.1534 |
0.0321 |
0.0372 |
1 |
|
C |
Male pattern baldness |
52,874 |
Hagenaars SP |
28196072 |
2017 |
ENSG00000221968 |
FADS3 |
rs28456 |
0.0164 |
0.6417 |
0.0106 |
0.0141 |
1 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000107186 |
MPDZ |
rs12340775 |
0.9207 |
0.9250 |
0.8516 |
0.8534 |
2 |
GABAergic (Lake) |
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000177374 |
HIC1 |
rs7213347 |
0.5069 |
0.4594 |
0.2329 |
0.3631 |
1 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000122691 |
TWIST1 |
rs67248060 |
0.9934 |
0.0847 |
0.0842 |
0.0842 |
1 |
endothelial (Darmanis) |
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000100376 |
FAM118A |
rs11556482 |
0.0461 |
0.9132 |
0.0421 |
0.0438 |
2 |
exDG (Habib) |
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000149600 |
COMMD7 |
rs4911106 |
0.0478 |
0.6157 |
0.0294 |
0.0571 |
1 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000183386 |
FHL3 |
rs4360494 |
0.0732 |
0.3907 |
0.0286 |
0.0364 |
1 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000151208 |
DLG5 |
rs2289308 |
0.0389 |
0.5373 |
0.0209 |
0.0287 |
1 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000117597 |
DIEXF |
rs10127937 |
0.1109 |
0.1766 |
0.0196 |
0.0657 |
2 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 1 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000110080 |
ST3GAL4 |
rs35600242 |
0.6220 |
0.0188 |
0.0117 |
0.0148 |
3 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 3 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000197461 |
PDGFA |
rs9691641 |
0.0786 |
0.1386 |
0.0109 |
0.0412 |
1 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000107186 |
MPDZ |
rs12340775 |
0.0959 |
0.9250 |
0.0887 |
0.1504 |
2 |
GABAergic (Lake) |
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000122691 |
TWIST1 |
rs67248060 |
0.9139 |
0.0847 |
0.0774 |
0.0805 |
1 |
endothelial (Darmanis) |
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000141013 |
GAS8 |
rs77270200 |
0.1166 |
0.4968 |
0.0579 |
0.0911 |
1 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000222019 |
URAHP |
rs74583214 |
0.2403 |
0.2293 |
0.0551 |
0.0822 |
3 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000003249 |
DBNDD1 |
rs77270200 |
0.1166 |
0.2992 |
0.0349 |
0.0759 |
2 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000168385 |
SEPT2 |
rs1134941 |
0.0230 |
1.0000 |
0.0230 |
0.0230 |
2 |
|
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000120071 |
KANSL1 |
rs199534 |
0.0306 |
0.3890 |
0.0119 |
0.0323 |
1 |
Purk1 (Lake), Purk2 (Lake) |
C |
Male-specific factors - Hair/balding pattern: Pattern 4 |
176,380 |
CTGLAB |
31427789 |
2019 |
ENSG00000203760 |
CENPW |
rs9375435 |
0.0502 |
0.1997 |
0.0100 |
0.0265 |
1 |
|
C |
Maternal effects on offspring birthweight |
86,379 |
Beaumont RN |
29309628 |
2018 |
ENSG00000198945 |
L3MBTL3 |
rs7740107 |
0.0363 |
1.0000 |
0.0363 |
0.0363 |
1 |
|
C |
Mucinous ovarian cancer |
42,090 |
Phelan M |
28346442 |
2017 |
ENSG00000189223 |
PAX8-AS1 |
rs4849174 |
0.3602 |
0.1004 |
0.0362 |
0.0673 |
5 |
|
C |
Multiple sclerosis |
26,621 |
Sawcer S |
21833088 |
2012 |
ENSG00000254858 |
MPV17L2 |
rs874628 |
0.8011 |
0.1905 |
0.1526 |
0.1526 |
1 |
|
C |
Multiple sclerosis |
38,582 |
International Multiple Sclerosis Genetics Consortium |
24076602 |
2013 |
ENSG00000138378 |
STAT4 |
rs4254532 |
0.0546 |
0.9178 |
0.0501 |
0.0516 |
1 |
neurons (Darmanis) |
C |
Multiple sclerosis |
38,582 |
International Multiple Sclerosis Genetics Consortium |
24076602 |
2013 |
ENSG00000123427 |
METTL21B |
rs10747783 |
0.0438 |
0.6379 |
0.0279 |
0.0465 |
1 |
|
C |
Multiple sclerosis |
38,582 |
International Multiple Sclerosis Genetics Consortium |
24076602 |
2013 |
ENSG00000254682 |
RP11-660L16.2 |
rs12807718 |
0.0778 |
0.3102 |
0.0241 |
0.0241 |
1 |
|
C |
Multiple sclerosis |
38,582 |
International Multiple Sclerosis Genetics Consortium |
24076602 |
2013 |
ENSG00000172890 |
NADSYN1 |
rs12807718 |
0.0778 |
0.2022 |
0.0157 |
0.0157 |
1 |
|
C |
Multiple sclerosis |
38,582 |
International Multiple Sclerosis Genetics Consortium |
24076602 |
2013 |
ENSG00000123297 |
TSFM |
rs10877019 |
0.0480 |
0.2394 |
0.0115 |
0.0347 |
1 |
|
C |
Myocardial infarction |
167,181 |
Nikpay M |
26343387 |
2015 |
ENSG00000119917 |
IFIT3 |
rs2266008 |
1.0000 |
0.2389 |
0.2389 |
0.2389 |
1 |
|
C |
Myocardial infarction |
167,181 |
Nikpay M |
26343387 |
2015 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0831 |
0.8171 |
0.0679 |
0.0742 |
1 |
|
C |
Myocardial infarction |
167,181 |
Nikpay M |
26343387 |
2015 |
ENSG00000164116 |
GUCY1A3 |
rs72689147 |
0.1871 |
0.3048 |
0.0570 |
0.1017 |
1 |
|
C |
Myocardial infarction |
167,181 |
Nikpay M |
26343387 |
2015 |
ENSG00000143126 |
CELSR2 |
rs7528419 |
0.6039 |
0.0293 |
0.0177 |
0.0177 |
1 |
|
C |
Myocardial infarction |
167,181 |
Nikpay M |
26343387 |
2015 |
ENSG00000115486 |
GGCX |
rs6743030 |
0.0453 |
0.3605 |
0.0163 |
0.0398 |
1 |
|
C |
Myocardial infarction |
167,181 |
Nikpay M |
26343387 |
2015 |
ENSG00000107798 |
LIPA |
rs1332329 |
0.1933 |
0.0737 |
0.0143 |
0.0405 |
5 |
|
C |
N20 Calculus of kidney and ureter |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169220 |
RGS14 |
rs10051765 |
0.9975 |
1.0000 |
0.9975 |
0.9975 |
1 |
|
C |
N20-N23 Urolithiasis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169220 |
RGS14 |
rs10051765 |
0.9577 |
1.0000 |
0.9577 |
0.9577 |
1 |
|
C |
N87 Dysplasia of cervix uteri |
245,494 |
Roslin Institute |
30349118 |
2018 |
ENSG00000110700 |
RPS13 |
rs16933837 |
0.0694 |
0.3647 |
0.0253 |
0.0592 |
1 |
|
C |
Narcolepsy |
12,307 |
Faraco J |
23459209 |
2013 |
ENSG00000103811 |
CTSH |
rs34593439 |
0.4958 |
0.9082 |
0.4503 |
0.4503 |
2 |
|
C |
Non-cancer illness code, self-reported: angina |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.1169 |
0.8959 |
0.1047 |
0.1121 |
1 |
|
C |
Non-cancer illness code, self-reported: angina |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.1671 |
0.5530 |
0.0924 |
0.1558 |
1 |
|
C |
Non-cancer illness code, self-reported: high cholesterol |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000084674 |
APOB |
rs1367117 |
0.6562 |
0.6851 |
0.4496 |
0.5578 |
1 |
|
C |
Non-cancer illness code, self-reported: high cholesterol |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000132793 |
LPIN3 |
rs6029636 |
0.0815 |
0.9324 |
0.0759 |
0.0782 |
1 |
|
C |
Non-cancer illness code, self-reported: high cholesterol |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000140830 |
TXNL4B |
rs2287997 |
0.4084 |
0.0550 |
0.0225 |
0.0336 |
1 |
|
C |
Non-cancer illness code, self-reported: high cholesterol |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000137154 |
RPS6 |
rs13300861 |
0.0337 |
0.5735 |
0.0193 |
0.0203 |
1 |
Glutamatergic (Lake), END (Habib) |
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000223705 |
NSUN5P1 |
rs62477737 |
0.5825 |
0.4215 |
0.2455 |
0.2455 |
1 |
|
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000129911 |
KLF16 |
rs12977787 |
0.0380 |
0.9587 |
0.0364 |
0.0364 |
1 |
|
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000140632 |
GLYR1 |
rs6500637 |
0.1324 |
0.2506 |
0.0332 |
0.0332 |
2 |
|
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000103510 |
KAT8 |
rs9972727 |
0.0995 |
0.2609 |
0.0260 |
0.0505 |
1 |
|
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000188878 |
FBF1 |
rs1046446 |
0.0827 |
0.2672 |
0.0221 |
0.0746 |
1 |
|
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000169247 |
SH3TC2 |
rs10050933 |
0.0235 |
0.9356 |
0.0219 |
0.0224 |
1 |
oligodendrocytes (Darmanis) |
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000156170 |
NDUFAF6 |
rs6984240 |
0.0652 |
0.3217 |
0.0210 |
0.0323 |
1 |
|
C |
Non-cancer illness code, self-reported: hypertension |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000181856 |
SLC2A4 |
rs5417 |
0.0279 |
0.4042 |
0.0113 |
0.0215 |
1 |
astrocytes (Darmanis) |
C |
Non-cancer illness code, self-reported: hypothyroidism/myxoedema |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000108774 |
RAB5C |
rs2230326 |
0.1630 |
0.5109 |
0.0833 |
0.1622 |
1 |
|
C |
Non-cancer illness code, self-reported: hypothyroidism/myxoedema |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000134825 |
TMEM258 |
rs174538 |
0.0302 |
0.9941 |
0.0300 |
0.0300 |
1 |
|
C |
Non-cancer illness code, self-reported: hypothyroidism/myxoedema |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000168071 |
CCDC88B |
rs479552 |
0.0288 |
0.9962 |
0.0287 |
0.0287 |
1 |
|
C |
Non-cancer illness code, self-reported: hypothyroidism/myxoedema |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000146830 |
GIGYF1 |
rs221781 |
0.0881 |
0.2183 |
0.0192 |
0.0738 |
1 |
|
C |
Non-cancer illness code, self-reported: hypothyroidism/myxoedema |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000130518 |
KIAA1683 |
rs7247222 |
0.0866 |
0.2068 |
0.0179 |
0.0197 |
1 |
|
C |
Non-cancer illness code, self-reported: hypothyroidism/myxoedema |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000130522 |
JUND |
rs12973608 |
0.0999 |
0.1568 |
0.0157 |
0.0553 |
1 |
NSC (Habib) |
C |
Non-cancer illness code, self-reported: osteoarthritis |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000163235 |
TGFA |
rs3771501 |
0.0711 |
0.4617 |
0.0328 |
0.0649 |
1 |
|
C |
Non-cancer illness code, self-reported: osteoarthritis |
289,307 |
CTGLAB |
31427789 |
2019 |
ENSG00000267100 |
ILF3-AS1 |
rs10408721 |
0.0120 |
0.9203 |
0.0110 |
0.0117 |
2 |
|
C |
Osteoarthritis of the hip or knee (hospital diagnosed) |
32,970 |
Zengini E |
29559693 |
2018 |
ENSG00000156253 |
RWDD2B |
rs7275747 |
0.0477 |
0.9154 |
0.0436 |
0.0477 |
1 |
|
C |
Pain type(s) experienced in last month: Headache |
385,698 |
CTGLAB |
31427789 |
2019 |
ENSG00000084093 |
REST |
rs781669 |
0.5576 |
0.0858 |
0.0478 |
0.0870 |
1 |
|
C |
Pain type(s) experienced in last month: Knee pain |
385,698 |
CTGLAB |
31427789 |
2019 |
ENSG00000267100 |
ILF3-AS1 |
rs10408721 |
0.0598 |
0.9203 |
0.0550 |
0.0559 |
2 |
|
C |
Primary biliary cirrhosis |
13,239 |
Alkes |
26394269 |
2015 |
ENSG00000213047 |
DENND1B |
rs2224873 |
0.1445 |
0.3458 |
0.0500 |
0.0959 |
1 |
|
C |
Primary biliary cirrhosis |
13,239 |
Alkes |
26394269 |
2015 |
ENSG00000073605 |
GSDMB |
rs8067378 |
0.1211 |
0.2299 |
0.0278 |
0.0497 |
2 |
|
C |
Primary sclerosing cholangitis |
14,890 |
Ji SG |
27992413 |
2017 |
ENSG00000105287 |
PRKD2 |
rs402072 |
0.1671 |
0.7489 |
0.1252 |
0.1615 |
2 |
|
C |
Proxy and clinically diagnosed Alzheimer's disease |
455,258 |
Jansen IE |
30617256 |
2018 |
ENSG00000138613 |
APH1B |
rs117618017 |
0.4105 |
0.9771 |
0.4011 |
0.4011 |
1 |
|
C |
Proxy and clinically diagnosed Alzheimer's disease |
455,258 |
Jansen IE |
30617256 |
2018 |
ENSG00000203710 |
CR1 |
rs679515 |
0.2191 |
0.9912 |
0.2171 |
0.2171 |
1 |
|
C |
Proxy and clinically diagnosed Alzheimer's disease |
455,258 |
Jansen IE |
30617256 |
2018 |
ENSG00000178226 |
PRSS36 |
rs78924645 |
0.0411 |
1.0000 |
0.0411 |
0.0411 |
1 |
|
C |
Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') |
78,647 |
CTGLAB |
31427789 |
2019 |
ENSG00000135441 |
BLOC1S1 |
rs3138141 |
0.6130 |
0.5599 |
0.3432 |
0.4665 |
1 |
|
C |
Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') |
78,647 |
CTGLAB |
31427789 |
2019 |
ENSG00000135437 |
RDH5 |
rs3138142 |
0.2801 |
0.8249 |
0.2311 |
0.3384 |
1 |
|
C |
Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') |
78,647 |
CTGLAB |
31427789 |
2019 |
ENSG00000182446 |
NPLOC4 |
rs9911460 |
0.1445 |
0.6826 |
0.0987 |
0.1117 |
3 |
astrocytes (Darmanis) |
C |
Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') |
78,647 |
CTGLAB |
31427789 |
2019 |
ENSG00000115380 |
EFEMP1 |
rs2009262 |
0.0216 |
0.4686 |
0.0101 |
0.0155 |
3 |
NSC (Habib), astrocytes (Darmanis) |
C |
Relative age voice broke (male) |
164,394 |
CTGLAB |
31427789 |
2019 |
ENSG00000131165 |
CHMP1A |
rs35414122 |
0.0203 |
0.8025 |
0.0163 |
0.0171 |
1 |
fetal_replicating (Darmanis) |
C |
Rheumatoid arthritis |
22,515 |
Okada Y |
24390342 |
2014 |
ENSG00000124608 |
AARS2 |
rs1044690 |
0.6428 |
0.1888 |
0.1213 |
0.1213 |
2 |
|
C |
Rheumatoid arthritis |
25,708 |
Stahl EA |
20453842 |
2010 |
ENSG00000101017 |
CD40 |
rs1883832 |
0.0727 |
0.3191 |
0.0232 |
0.0599 |
1 |
|
C |
Rheumatoid arthritis |
22,515 |
Okada Y |
24390342 |
2014 |
ENSG00000112062 |
MAPK14 |
rs9380547 |
0.0412 |
0.5576 |
0.0230 |
0.0248 |
1 |
|
C |
Serous invasive ovarian cancer |
54,990 |
Phelan M |
28346442 |
2017 |
ENSG00000164695 |
CHMP4C |
rs78724141 |
0.1501 |
0.4534 |
0.0681 |
0.1144 |
1 |
|
C |
Sleeplessness / insomnia |
386,078 |
CTGLAB |
31427789 |
2019 |
ENSG00000138111 |
TMEM180 |
rs3808937 |
0.0273 |
0.9880 |
0.0270 |
0.0270 |
2 |
|
C |
Sleeplessness / insomnia |
386,078 |
CTGLAB |
31427789 |
2019 |
ENSG00000182179 |
UBA7 |
rs4688760 |
0.6693 |
0.0350 |
0.0234 |
0.0242 |
1 |
|
C |
Sleeplessness / insomnia |
386,078 |
CTGLAB |
31427789 |
2019 |
ENSG00000186834 |
HEXIM1 |
rs9894577 |
0.4456 |
0.0509 |
0.0227 |
0.0260 |
1 |
|
C |
Sleeplessness / insomnia |
386,078 |
CTGLAB |
31427789 |
2019 |
ENSG00000182134 |
TDRKH |
rs9017 |
0.0758 |
0.2403 |
0.0182 |
0.0182 |
1 |
|
C |
Sleeplessness / insomnia |
386,078 |
CTGLAB |
31427789 |
2019 |
ENSG00000163431 |
LMOD1 |
rs4494199 |
0.0183 |
0.8827 |
0.0162 |
0.0162 |
1 |
|
C |
Snoring |
359,498 |
CTGLAB |
31427789 |
2019 |
ENSG00000245573 |
BDNF-AS |
rs2049045 |
0.3422 |
0.2729 |
0.0934 |
0.1255 |
2 |
|
C |
Snoring |
359,498 |
CTGLAB |
31427789 |
2019 |
ENSG00000152359 |
POC5 |
rs6881648 |
0.0515 |
0.3653 |
0.0188 |
0.0467 |
1 |
|
C |
Snoring |
359,498 |
CTGLAB |
31427789 |
2019 |
ENSG00000103496 |
STX4 |
rs58726213 |
0.0432 |
0.3186 |
0.0138 |
0.0341 |
1 |
|
C |
Systemic lupus erythematosus |
6,232 |
Bentham J |
26502338 |
2015 |
ENSG00000161179 |
YDJC |
rs5994638 |
0.0498 |
0.2558 |
0.0127 |
0.0339 |
1 |
Mic (Darmanis) |
C |
Type 1 diabetes(cc) |
17,091 |
Onengut Gumuscu S |
25751624 |
2015 |
ENSG00000103811 |
CTSH |
rs34593439 |
0.7338 |
0.9082 |
0.6664 |
0.6664 |
2 |
|
C |
Type 1 diabetes(cc) |
17,091 |
Onengut Gumuscu S |
25751624 |
2015 |
ENSG00000176909 |
MAMSTR |
rs603985 |
0.0904 |
0.1701 |
0.0154 |
0.0201 |
1 |
|
C |
Type 1 diabetes(meta) |
14,245 |
Onengut Gumuscu S |
25751624 |
2015 |
ENSG00000103811 |
CTSH |
rs34593439 |
0.5773 |
0.9082 |
0.5243 |
0.5243 |
2 |
|
C |
Type 2 Diabetes |
659,256 |
Xue A |
30054458 |
2018 |
ENSG00000113231 |
PDE8B |
rs6878122 |
0.8078 |
0.1540 |
0.1244 |
0.1244 |
2 |
Glutamatergic (Lake), GABAergic (Lake), Pericytes (Lake), exDG (Habib) |
C |
Type 2 Diabetes |
659,256 |
Xue A |
30054458 |
2018 |
ENSG00000074755 |
ZZEF1 |
rs8068804 |
0.6924 |
0.0838 |
0.0580 |
0.0911 |
1 |
|
C |
Type 2 Diabetes |
898,130 |
DIAGRAM |
30297969 |
2018 |
ENSG00000150967 |
ABCB9 |
rs1727307 |
0.3077 |
0.1831 |
0.0563 |
0.0568 |
2 |
|
C |
Type 2 Diabetes |
659,256 |
Xue A |
30054458 |
2018 |
ENSG00000029534 |
ANK1 |
rs6989203 |
0.2234 |
0.2067 |
0.0462 |
0.0638 |
1 |
GABAergic (Lake) |
C |
Type 2 Diabetes |
659,256 |
Xue A |
30054458 |
2018 |
ENSG00000159202 |
UBE2Z |
rs12940898 |
0.0785 |
0.3537 |
0.0278 |
0.1080 |
1 |
|
C |
Type 2 Diabetes |
159,208 |
DIAGRAM |
28566273 |
2017 |
ENSG00000149084 |
HSD17B12 |
rs35251247 |
0.0330 |
0.7861 |
0.0259 |
0.0366 |
1 |
GABAergic (Lake) |
C |
Type 2 Diabetes |
898,130 |
DIAGRAM |
30297969 |
2018 |
ENSG00000132846 |
ZBED3 |
rs4457053 |
0.9999 |
0.0190 |
0.0190 |
0.0190 |
1 |
|
C |
Type 2 Diabetes |
659,256 |
Xue A |
30054458 |
2018 |
ENSG00000152359 |
POC5 |
rs6874626 |
0.0859 |
0.1363 |
0.0117 |
0.0255 |
1 |
|
C |
Type 2 Diabetes |
659,256 |
Xue A |
30054458 |
2018 |
ENSG00000171056 |
SOX7 |
rs6601521 |
0.0331 |
0.3184 |
0.0105 |
0.0106 |
1 |
endothelial (Darmanis) |
C |
Type 2 Diabetes (adjusted for BMI) |
898,130 |
DIAGRAM |
30297969 |
2018 |
ENSG00000029534 |
ANK1 |
rs516946 |
1.0000 |
0.0227 |
0.0227 |
0.0227 |
1 |
GABAergic (Lake) |
C |
Type 2 Diabetes (adjusted for BMI) |
898,130 |
DIAGRAM |
30297969 |
2018 |
ENSG00000150967 |
ABCB9 |
rs1727307 |
0.1040 |
0.1831 |
0.0190 |
0.0198 |
2 |
|
C |
Type 2 Diabetes (adjusted for BMI) |
898,130 |
DIAGRAM |
30297969 |
2018 |
ENSG00000132846 |
ZBED3 |
rs4457053 |
1.0000 |
0.0190 |
0.0190 |
0.0190 |
1 |
|
C |
Type 2 diabetes |
69,033 |
Morris AP |
22885922 |
2012 |
ENSG00000113231 |
PDE8B |
rs6878122 |
0.6041 |
0.1540 |
0.0930 |
0.0930 |
2 |
Glutamatergic (Lake), GABAergic (Lake), Pericytes (Lake), exDG (Habib) |
C |
Type 2 diabetes |
69,033 |
Morris AP |
22885922 |
2012 |
ENSG00000029534 |
ANK1 |
rs6989203 |
0.2884 |
0.2067 |
0.0596 |
0.0758 |
1 |
GABAergic (Lake) |
C |
Type 2 diabetes |
2,931 |
Saxena R |
17463246 |
2007 |
ENSG00000261662 |
RP5-1042I8.7 |
rs10923931 |
0.8650 |
0.0133 |
0.0115 |
0.0127 |
1 |
|
C |
Type 2 diabetes autosomal |
70,127 |
Bonas-Guarch S |
29358691 |
2018 |
ENSG00000118971 |
CCND2 |
rs76895963 |
0.8492 |
1.0000 |
0.8492 |
0.8492 |
1 |
OPC_Cer (Lake) |
C |
Ulcerative colitis |
26,405 |
Anderson CA |
21297633 |
2011 |
ENSG00000140319 |
SRP14 |
rs2291619 |
1.0000 |
0.8354 |
0.8354 |
0.8354 |
1 |
Glutamatergic (Lake), NSC (Habib) |
C |
Ulcerative colitis |
27,432 |
Liu JZ |
26192919 |
2015 |
ENSG00000013725 |
CD6 |
rs11230563 |
0.9434 |
0.4815 |
0.4543 |
0.4543 |
1 |
|
C |
Ulcerative colitis |
26,405 |
Anderson CA |
21297633 |
2011 |
ENSG00000197894 |
ADH5 |
rs17507714 |
0.9979 |
0.1233 |
0.1230 |
0.1230 |
4 |
|
C |
Ulcerative colitis |
26,405 |
Anderson CA |
21297633 |
2011 |
ENSG00000138759 |
FRAS1 |
rs1385133 |
0.9996 |
0.1026 |
0.1026 |
0.1026 |
6 |
Glutamatergic (Lake), GABAergic (Lake) |
C |
Ulcerative colitis |
26,405 |
Anderson CA |
21297633 |
2011 |
ENSG00000148655 |
C10orf11 |
rs7073851 |
1.0000 |
0.0940 |
0.0940 |
0.0940 |
3 |
Ast_Cer (Lake), OPC (Lake), Microglia (Lake), Mic (Darmanis) |
C |
Ulcerative colitis |
27,432 |
Liu JZ |
26192919 |
2015 |
ENSG00000107882 |
SUFU |
rs2274351 |
0.5756 |
0.1590 |
0.0915 |
0.0939 |
1 |
|
C |
Ulcerative colitis |
27,432 |
Liu JZ |
26192919 |
2015 |
ENSG00000267673 |
FDX1L |
rs12720356 |
0.6381 |
0.0924 |
0.0589 |
0.0589 |
2 |
|
C |
Ulcerative colitis |
26,405 |
Anderson CA |
21297633 |
2011 |
ENSG00000165684 |
SNAPC4 |
rs4077515 |
0.1598 |
0.2028 |
0.0324 |
0.0680 |
3 |
|
C |
Ulcerative colitis |
27,432 |
Liu JZ |
26192919 |
2015 |
ENSG00000160013 |
PTGIR |
rs11083840 |
0.9996 |
0.0323 |
0.0323 |
0.0323 |
1 |
|
C |
Ulcerative colitis |
27,432 |
Liu JZ |
26192919 |
2015 |
ENSG00000197083 |
ZNF300P1 |
rs11739677 |
0.0527 |
0.4563 |
0.0240 |
0.0460 |
1 |
|
C |
Ulcerative colitis |
27,432 |
Liu JZ |
26192919 |
2015 |
ENSG00000224870 |
RP4-758J18.2 |
rs1240708 |
0.0677 |
0.3317 |
0.0225 |
0.0225 |
2 |
|
C |
Ulcerative colitis |
26,405 |
Anderson CA |
21297633 |
2011 |
ENSG00000225697 |
SLC26A6 |
rs13324142 |
0.3041 |
0.0683 |
0.0208 |
0.0373 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: Angina |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.1746 |
0.5530 |
0.0965 |
0.1597 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: Angina |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.0556 |
0.8959 |
0.0499 |
0.0571 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000159256 |
MORC3 |
rs62229372 |
0.2518 |
0.4357 |
0.1097 |
0.1913 |
2 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000223705 |
NSUN5P1 |
rs62477737 |
0.1960 |
0.4215 |
0.0826 |
0.0826 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000181856 |
SLC2A4 |
rs5417 |
0.0810 |
0.4042 |
0.0327 |
0.0626 |
1 |
astrocytes (Darmanis) |
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000161204 |
ABCF3 |
rs35315125 |
0.0382 |
0.7188 |
0.0275 |
0.0488 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000103510 |
KAT8 |
rs9972727 |
0.1013 |
0.2609 |
0.0264 |
0.0416 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000169247 |
SH3TC2 |
rs10050933 |
0.0169 |
0.9356 |
0.0158 |
0.0161 |
1 |
oligodendrocytes (Darmanis) |
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000138430 |
OLA1 |
rs6737629 |
0.0363 |
0.4340 |
0.0158 |
0.0346 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000174456 |
C12orf76 |
rs11068810 |
0.1041 |
0.1306 |
0.0136 |
0.0626 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000115825 |
PRKD3 |
rs2540977 |
0.0705 |
0.1755 |
0.0124 |
0.0366 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000213445 |
SIPA1 |
rs2306363 |
0.0188 |
0.5918 |
0.0111 |
0.0111 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000163785 |
RYK |
rs9865808 |
0.0767 |
0.1448 |
0.0111 |
0.0386 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000205189 |
ZBTB10 |
rs7817124 |
0.1660 |
0.0630 |
0.0105 |
0.0477 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000159479 |
MED8 |
rs11172 |
0.0162 |
0.6399 |
0.0104 |
0.0166 |
1 |
|
C |
Vascular/heart problems diagnosed by doctor: High blood pressure |
385,699 |
CTGLAB |
31427789 |
2019 |
ENSG00000164938 |
TP53INP1 |
rs896853 |
0.0244 |
0.4209 |
0.0103 |
0.0149 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000162613 |
FUBP1 |
rs34517439 |
1.0000 |
0.9934 |
0.9934 |
0.9934 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000198945 |
L3MBTL3 |
rs7740107 |
0.9468 |
1.0000 |
0.9468 |
0.9468 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000271780 |
RP11-1017G21.5 |
rs2448241 |
0.3880 |
1.0000 |
0.3880 |
0.3880 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000160685 |
ZBTB7B |
rs76798800 |
0.8280 |
0.2539 |
0.2103 |
0.2472 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000049323 |
LTBP1 |
rs116072427 |
0.3931 |
0.5338 |
0.2098 |
0.3324 |
2 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000100418 |
DESI1 |
rs55906059 |
0.2524 |
0.7296 |
0.1841 |
0.2920 |
4 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000168899 |
VAMP5 |
rs1374370 |
0.2563 |
0.6733 |
0.1726 |
0.2354 |
1 |
END (Habib) |
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000198911 |
SREBF2 |
rs41311445 |
0.9692 |
0.1756 |
0.1701 |
0.1701 |
1 |
|
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000149084 |
HSD17B12 |
rs35251247 |
0.2127 |
0.7861 |
0.1672 |
0.2580 |
1 |
GABAergic (Lake) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000269858 |
EGLN2 |
rs35405967 |
0.3095 |
0.4909 |
0.1520 |
0.2665 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000168016 |
TRANK1 |
rs115774037 |
0.7975 |
0.1744 |
0.1391 |
0.2279 |
2 |
GABAergic (Habib) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163946 |
FAM208A |
rs6762851 |
0.7678 |
0.1579 |
0.1212 |
0.1216 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000135547 |
HEY2 |
rs1159974 |
0.1985 |
0.5171 |
0.1026 |
0.1130 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000105948 |
TTC26 |
rs13233916 |
0.1139 |
0.8875 |
0.1011 |
0.1011 |
1 |
NSC (Habib) |
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000107185 |
RGP1 |
rs2236288 |
0.1457 |
0.5865 |
0.0854 |
0.0854 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134308 |
YWHAQ |
rs10203320 |
0.0972 |
0.7502 |
0.0729 |
0.0846 |
2 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000101412 |
E2F1 |
rs17404047 |
0.1840 |
0.3512 |
0.0646 |
0.1821 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163702 |
IL17RC |
rs2270894 |
0.9971 |
0.0613 |
0.0611 |
0.0611 |
3 |
|
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000189339 |
SLC35E2B |
rs111946117 |
0.0647 |
0.9370 |
0.0607 |
0.0653 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000131323 |
TRAF3 |
rs7145882 |
0.0740 |
0.8066 |
0.0597 |
0.0609 |
1 |
|
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000197381 |
ADARB1 |
rs79585412 |
0.0576 |
0.9722 |
0.0560 |
0.0560 |
2 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000175826 |
CTDNEP1 |
rs77234976 |
0.2912 |
0.1828 |
0.0532 |
0.0748 |
2 |
|
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000129625 |
REEP5 |
rs154346 |
0.1911 |
0.2747 |
0.0525 |
0.0707 |
1 |
Glutamatergic (Lake), GABAergic (Lake) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000055118 |
KCNH2 |
rs11771808 |
0.0524 |
0.9445 |
0.0495 |
0.0537 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000189403 |
HMGB1 |
rs3742305 |
0.0881 |
0.5585 |
0.0492 |
0.0863 |
1 |
END (Habib) |
C |
Weight |
133,723 |
Randall JC |
23754948 |
2013 |
ENSG00000172260 |
NEGR1 |
rs7531118 |
0.1160 |
0.4221 |
0.0489 |
0.0507 |
1 |
Glutamatergic (Lake), GABAergic (Lake), Glutamatergic (Habib) |
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000138031 |
ADCY3 |
rs10182458 |
0.0455 |
0.9679 |
0.0441 |
0.0441 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000172613 |
RAD9A |
rs61734601 |
0.0424 |
0.9957 |
0.0422 |
0.0422 |
1 |
Glutamatergic (Lake), Purk2 (Lake) |
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000139428 |
MMAB |
rs9919738 |
0.0816 |
0.4520 |
0.0369 |
0.0556 |
2 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000101246 |
ARFRP1 |
rs4809221 |
0.0720 |
0.5060 |
0.0365 |
0.0674 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000270210 |
RP11-373D23.3 |
rs7589485 |
0.0534 |
0.6803 |
0.0363 |
0.0526 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000007312 |
CD79B |
rs2532111 |
0.0954 |
0.3602 |
0.0344 |
0.0827 |
1 |
endothelial (Darmanis) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000214113 |
LYRM4 |
rs6925249 |
0.0487 |
0.6963 |
0.0339 |
0.0390 |
3 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000115548 |
KDM3A |
rs4832298 |
0.1040 |
0.3249 |
0.0338 |
0.0612 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000164946 |
FREM1 |
rs10733289 |
0.1976 |
0.1707 |
0.0337 |
0.0545 |
4 |
GABAergic (Lake) |
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000085721 |
RRN3 |
rs12928424 |
0.0581 |
0.5797 |
0.0337 |
0.0373 |
2 |
|
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000110921 |
MVK |
rs1541597 |
0.0338 |
0.8728 |
0.0295 |
0.0295 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000150867 |
PIP4K2A |
rs4748810 |
0.0294 |
0.9994 |
0.0293 |
0.0293 |
1 |
Oligodendrocytes (Lake), Oligodendrocytes (Habib) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000155034 |
FBXL18 |
rs7789129 |
0.0312 |
0.9388 |
0.0293 |
0.0293 |
1 |
|
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000146067 |
FAM193B |
rs244721 |
0.1053 |
0.2742 |
0.0289 |
0.0289 |
3 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000144554 |
FANCD2 |
rs6796538 |
0.0696 |
0.4056 |
0.0282 |
0.0377 |
1 |
fetal_replicating (Darmanis) |
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000134198 |
TSPAN2 |
rs72697933 |
0.0809 |
0.3481 |
0.0282 |
0.0501 |
3 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000167674 |
HDGFRP2 |
rs76608582 |
0.0282 |
0.9755 |
0.0275 |
0.0275 |
2 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000108349 |
CASC3 |
rs632224 |
0.3182 |
0.0837 |
0.0266 |
0.0638 |
3 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000041353 |
RAB27B |
rs3764512 |
0.0485 |
0.5423 |
0.0263 |
0.0472 |
1 |
|
C |
Weight |
133,723 |
Randall JC |
23754948 |
2013 |
ENSG00000135587 |
SMPD2 |
rs9487100 |
0.0591 |
0.4331 |
0.0256 |
0.0402 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000161217 |
PCYT1A |
rs712012 |
0.0248 |
0.9999 |
0.0248 |
0.0248 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000150938 |
CRIM1 |
rs14291 |
0.0262 |
0.8917 |
0.0233 |
0.0233 |
1 |
END (Habib) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000116649 |
SRM |
rs2791643 |
0.1063 |
0.2186 |
0.0232 |
0.0315 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000170634 |
ACYP2 |
rs41385746 |
0.0752 |
0.2886 |
0.0217 |
0.0499 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000172201 |
ID4 |
rs9350100 |
0.1470 |
0.1451 |
0.0213 |
0.0642 |
1 |
Astrocytes (Habib) |
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000104447 |
TRPS1 |
rs2721940 |
0.0459 |
0.4602 |
0.0211 |
0.0401 |
1 |
GABAergic (Lake), Astrocytes (Lake), Ast_Cer (Lake), NSC (Habib) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000117280 |
RAB7L1 |
rs823118 |
0.0581 |
0.3629 |
0.0211 |
0.0475 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000141556 |
TBCD |
rs62078078 |
0.4547 |
0.0452 |
0.0205 |
0.0209 |
4 |
|
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000123737 |
EXOSC9 |
rs6821305 |
0.5810 |
0.0349 |
0.0203 |
0.0232 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000078304 |
PPP2R5C |
rs1741143 |
0.0234 |
0.8546 |
0.0200 |
0.0229 |
1 |
Glutamatergic (Lake) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000120071 |
KANSL1 |
rs11656151 |
0.0204 |
0.9700 |
0.0198 |
0.0198 |
2 |
Purk1 (Lake), Purk2 (Lake) |
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000101104 |
PABPC1L |
rs6031847 |
0.0856 |
0.2261 |
0.0194 |
0.0309 |
1 |
|
C |
Weight |
133,723 |
Randall JC |
23754948 |
2013 |
ENSG00000178952 |
TUFM |
rs7187776 |
0.0392 |
0.4793 |
0.0188 |
0.0249 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000185684 |
EP400NL |
rs11838262 |
0.0539 |
0.3437 |
0.0185 |
0.0464 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000133065 |
SLC41A1 |
rs823074 |
0.0963 |
0.1899 |
0.0183 |
0.0581 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000180921 |
FAM83H |
rs9650469 |
0.0310 |
0.5583 |
0.0173 |
0.0318 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000160094 |
ZNF362 |
rs55745410 |
0.0899 |
0.1862 |
0.0167 |
0.0207 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163393 |
SLC22A15 |
rs10754390 |
0.1378 |
0.1205 |
0.0166 |
0.0171 |
1 |
Oligodendrocytes (Lake) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169641 |
LUZP1 |
rs1952527 |
0.0352 |
0.4697 |
0.0165 |
0.0214 |
1 |
GABAergic (Lake) |
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000186704 |
DTX2P1 |
rs2539502 |
0.0655 |
0.2524 |
0.0165 |
0.0449 |
3 |
|
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000157045 |
NTAN1 |
rs12928424 |
0.0581 |
0.2805 |
0.0163 |
0.0496 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000231160 |
RP11-617D20.1 |
rs9522 |
0.0161 |
0.9969 |
0.0161 |
0.0161 |
2 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000117450 |
PRDX1 |
rs115092994 |
0.2113 |
0.0747 |
0.0158 |
0.0694 |
2 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000227775 |
RP1-283E3.4 |
rs72634819 |
0.2055 |
0.0767 |
0.0158 |
0.0298 |
6 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000198890 |
PRMT6 |
rs1730865 |
0.0294 |
0.5155 |
0.0152 |
0.0325 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000260329 |
RP11-412D9.4 |
rs1024853 |
0.0361 |
0.4086 |
0.0148 |
0.0325 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000223496 |
EXOSC6 |
rs4985407 |
0.0147 |
1.0000 |
0.0147 |
0.0147 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000261556 |
RP11-296I10.6 |
rs4985407 |
0.0147 |
1.0000 |
0.0147 |
0.0147 |
1 |
|
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000162971 |
TYW5 |
rs281791 |
0.0376 |
0.3780 |
0.0142 |
0.0407 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000102924 |
CBLN1 |
rs2908884 |
0.1069 |
0.1326 |
0.0142 |
0.0580 |
2 |
|
C |
Weight |
133,723 |
Randall JC |
23754948 |
2013 |
ENSG00000152359 |
POC5 |
rs6874626 |
0.1006 |
0.1363 |
0.0137 |
0.0179 |
1 |
|
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000214401 |
KANSL1-AS1 |
rs11653367 |
0.3144 |
0.0428 |
0.0134 |
0.0307 |
2 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000101193 |
GID8 |
rs3746756 |
0.2071 |
0.0648 |
0.0134 |
0.0260 |
1 |
|
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000138430 |
OLA1 |
rs6737629 |
0.0301 |
0.4340 |
0.0131 |
0.0374 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000010327 |
STAB1 |
rs36012032 |
0.0480 |
0.2687 |
0.0129 |
0.0452 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000074755 |
ZZEF1 |
rs8068804 |
0.1521 |
0.0838 |
0.0127 |
0.0459 |
1 |
|
C |
Weight |
354,838 |
Nealelab |
Nealelab |
2018 |
ENSG00000166913 |
YWHAB |
rs16989481 |
0.0137 |
0.9145 |
0.0125 |
0.0146 |
1 |
Glutamatergic (Lake), GABAergic (Lake), exCA1 (Habib) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134245 |
WNT2B |
rs12029985 |
0.0227 |
0.5489 |
0.0125 |
0.0210 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000063438 |
AHRR |
rs9654451 |
0.0144 |
0.8585 |
0.0123 |
0.0138 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000113070 |
HBEGF |
rs4150214 |
0.1514 |
0.0812 |
0.0123 |
0.0844 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000103056 |
SMPD3 |
rs4783558 |
0.0791 |
0.1505 |
0.0119 |
0.0377 |
1 |
Glutamatergic (Lake) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000069275 |
NUCKS1 |
rs823074 |
0.0963 |
0.1211 |
0.0117 |
0.0505 |
1 |
Glutamatergic (Lake), NSC (Habib) |
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000069956 |
MAPK6 |
rs2414128 |
0.0193 |
0.5962 |
0.0115 |
0.0117 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000104228 |
TRIM35 |
rs17446091 |
0.0115 |
1.0000 |
0.0115 |
0.0115 |
2 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000119509 |
INVS |
rs7020988 |
0.0240 |
0.4765 |
0.0114 |
0.0200 |
1 |
|
C |
Weight |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000071967 |
CYBRD1 |
rs56372408 |
0.1313 |
0.0864 |
0.0113 |
0.0296 |
4 |
|
C |
Weight |
360,116 |
Nealelab |
Nealelab |
2018 |
ENSG00000109534 |
GAR1 |
rs10365 |
0.0113 |
1.0000 |
0.0113 |
0.0113 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000131462 |
TUBG1 |
rs2292750 |
0.0112 |
0.9873 |
0.0111 |
0.0111 |
1 |
|
C |
Weight |
385,473 |
CTGLAB |
31427789 |
2019 |
ENSG00000077380 |
DYNC1I2 |
rs12692974 |
0.0163 |
0.6239 |
0.0102 |
0.0159 |
1 |
|
C |
Wheeze or whistling in the chest in last year |
379,150 |
CTGLAB |
31427789 |
2019 |
ENSG00000233016 |
SNHG7 |
rs11145848 |
0.1295 |
0.7303 |
0.0945 |
0.1292 |
1 |
|
C |
Wheeze or whistling in the chest in last year |
379,150 |
CTGLAB |
31427789 |
2019 |
ENSG00000134987 |
WDR36 |
rs79881201 |
0.1425 |
0.1059 |
0.0151 |
0.0328 |
3 |
|
C |
angina |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.2040 |
0.5530 |
0.1128 |
0.2218 |
1 |
|
C |
angina |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000182511 |
FES |
rs4932376 |
0.0984 |
0.1164 |
0.0114 |
0.0295 |
1 |
|
C |
asthma |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000138688 |
KIAA1109 |
rs72687029 |
0.0359 |
0.4572 |
0.0164 |
0.0307 |
1 |
Glutamatergic (Lake), GABAergic (Lake), Pericytes (Lake) |
C |
deep venous thrombosis (dvt) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000101000 |
PROCR |
rs867186 |
0.0393 |
0.3779 |
0.0148 |
0.0206 |
1 |
|
C |
eye/eyelid problem |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000147883 |
CDKN2B |
rs10120688 |
0.0481 |
0.3009 |
0.0145 |
0.0160 |
1 |
|
C |
gall bladder disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000105677 |
TMEM147 |
rs2251124 |
0.1251 |
0.1916 |
0.0240 |
0.0582 |
1 |
|
C |
gall bladder disease |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000236144 |
AD000090.2 |
rs2251124 |
0.1251 |
0.1158 |
0.0145 |
0.0600 |
2 |
|
C |
gout |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169231 |
THBS3 |
rs760077 |
0.1942 |
1.0000 |
0.1942 |
0.1942 |
1 |
astrocytes (Darmanis) |
C |
gout |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000165449 |
SLC16A9 |
rs1171614 |
0.2708 |
0.3462 |
0.0937 |
0.2610 |
2 |
|
C |
gout |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000185499 |
MUC1 |
rs760077 |
0.1942 |
0.2323 |
0.0451 |
0.0563 |
1 |
|
C |
gout |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169241 |
SLC50A1 |
rs4971073 |
0.0369 |
0.5637 |
0.0208 |
0.0209 |
1 |
|
C |
hayfever/allergic rhinitis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000197728 |
RPS26 |
rs1131017 |
0.0265 |
1.0000 |
0.0265 |
0.0265 |
1 |
|
C |
heart arrhythmia |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000105974 |
CAV1 |
rs1997571 |
0.2354 |
0.8117 |
0.1911 |
0.2399 |
1 |
|
C |
heart arrhythmia |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000116132 |
PRRX1 |
rs651386 |
0.1036 |
0.2517 |
0.0261 |
0.0261 |
2 |
|
C |
heart arrhythmia |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000105971 |
CAV2 |
rs1997571 |
0.2354 |
0.0809 |
0.0191 |
0.0360 |
1 |
endothelial (Darmanis) |
C |
heart attack/myocardial infarction |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000143126 |
CELSR2 |
rs660240 |
0.1380 |
0.8959 |
0.1236 |
0.1290 |
1 |
|
C |
heart attack/myocardial infarction |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs629301 |
0.1703 |
0.5530 |
0.0942 |
0.1742 |
1 |
|
C |
heart attack/myocardial infarction |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0414 |
0.8171 |
0.0339 |
0.0410 |
1 |
|
C |
heart/cardiac problem |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000134222 |
PSRC1 |
rs646776 |
0.2778 |
0.4418 |
0.1227 |
0.2352 |
1 |
|
C |
heart/cardiac problem |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000186063 |
AIDA |
rs35700460 |
0.0487 |
0.8171 |
0.0398 |
0.0464 |
1 |
|
C |
heart/cardiac problem |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000182511 |
FES |
rs4932376 |
0.0906 |
0.1164 |
0.0105 |
0.0110 |
1 |
|
C |
high cholesterol |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000084674 |
APOB |
rs1367117 |
0.6532 |
0.6851 |
0.4476 |
0.5567 |
1 |
|
C |
high cholesterol |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000228782 |
MRPL45P2 |
rs9894179 |
0.0144 |
0.7901 |
0.0114 |
0.0117 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000196196 |
HRCT1 |
rs76452347 |
1.0000 |
1.0000 |
1.0000 |
1.0000 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000235387 |
LINC00961 |
rs76452347 |
1.0000 |
0.8780 |
0.8780 |
0.8780 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000159256 |
MORC3 |
rs8131909 |
0.3333 |
0.4161 |
0.1387 |
0.2228 |
2 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000181856 |
SLC2A4 |
rs5418 |
0.3157 |
0.4042 |
0.1276 |
0.2347 |
1 |
astrocytes (Darmanis) |
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000164307 |
ERAP1 |
rs27433 |
0.1062 |
0.9636 |
0.1023 |
0.1023 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000161204 |
ABCF3 |
rs35315125 |
0.1081 |
0.7188 |
0.0777 |
0.1108 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000141076 |
CIRH1A |
rs74886619 |
0.0697 |
1.0000 |
0.0697 |
0.0697 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000164116 |
GUCY1A3 |
rs11724647 |
0.2321 |
0.2857 |
0.0663 |
0.1454 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000223705 |
NSUN5P1 |
rs62477737 |
0.1258 |
0.4215 |
0.0530 |
0.0530 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000159640 |
ACE |
rs6504163 |
0.0658 |
0.5669 |
0.0373 |
0.0578 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000171044 |
XKR6 |
rs10090444 |
0.0519 |
0.7025 |
0.0364 |
0.0560 |
1 |
Glutamatergic (Lake), Gran (Lake), Purk1 (Lake), Purk2 (Lake) |
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169247 |
SH3TC2 |
rs10050933 |
0.0345 |
0.9356 |
0.0323 |
0.0330 |
1 |
oligodendrocytes (Darmanis) |
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000008130 |
NADK |
rs1014988 |
0.0267 |
0.9846 |
0.0263 |
0.0263 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000138430 |
OLA1 |
rs6737629 |
0.0516 |
0.4340 |
0.0224 |
0.0525 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000103510 |
KAT8 |
rs4527034 |
0.0300 |
0.7391 |
0.0222 |
0.0358 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000188878 |
FBF1 |
rs11077798 |
0.1932 |
0.0875 |
0.0169 |
0.0793 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000156170 |
NDUFAF6 |
rs6984240 |
0.0514 |
0.3217 |
0.0165 |
0.0292 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000149577 |
SIDT2 |
rs1871757 |
0.0503 |
0.2876 |
0.0145 |
0.0482 |
1 |
|
C |
hypertension |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000174456 |
C12orf76 |
rs11068808 |
0.0829 |
0.1409 |
0.0117 |
0.0574 |
1 |
|
C |
hypothyroidism/myxoedema |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000108774 |
RAB5C |
rs731151 |
0.1503 |
0.4840 |
0.0727 |
0.1207 |
1 |
|
C |
hypothyroidism/myxoedema |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000168071 |
CCDC88B |
rs479552 |
0.0463 |
0.9962 |
0.0461 |
0.0461 |
1 |
|
C |
hypothyroidism/myxoedema |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000198917 |
C9orf114 |
rs112086410 |
0.0404 |
0.8921 |
0.0360 |
0.0551 |
1 |
|
C |
hypothyroidism/myxoedema |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000160447 |
PKN3 |
rs13289095 |
0.0740 |
0.3477 |
0.0257 |
0.0604 |
1 |
|
C |
hypothyroidism/myxoedema |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000146830 |
GIGYF1 |
rs221781 |
0.0799 |
0.2183 |
0.0174 |
0.0682 |
1 |
|
C |
hypothyroidism/myxoedema |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000130522 |
JUND |
rs12973608 |
0.0838 |
0.1568 |
0.0131 |
0.0510 |
1 |
NSC (Habib) |
C |
hypothyroidism/myxoedema |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000130518 |
KIAA1683 |
rs7247222 |
0.0603 |
0.2068 |
0.0125 |
0.0143 |
1 |
|
C |
joint disorder |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163235 |
TGFA |
rs3771501 |
0.0678 |
0.4617 |
0.0313 |
0.0664 |
1 |
|
C |
joint disorder |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000131165 |
CHMP1A |
rs62068708 |
0.1753 |
0.0810 |
0.0142 |
0.0158 |
2 |
fetal_replicating (Darmanis) |
C |
joint disorder |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000172992 |
DCAKD |
rs8071429 |
0.0136 |
0.9774 |
0.0133 |
0.0133 |
1 |
|
C |
kidney stone/ureter stone/bladder stone |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169220 |
RGS14 |
rs10051765 |
0.7628 |
1.0000 |
0.7628 |
0.7628 |
1 |
|
C |
osteoarthritis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000163235 |
TGFA |
rs3771501 |
0.1236 |
0.4617 |
0.0570 |
0.1096 |
1 |
|
C |
osteoarthritis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000267100 |
ILF3-AS1 |
rs10408721 |
0.0227 |
0.9203 |
0.0209 |
0.0217 |
2 |
|
C |
osteoarthritis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000131165 |
CHMP1A |
rs62068708 |
0.2200 |
0.0810 |
0.0178 |
0.0191 |
2 |
fetal_replicating (Darmanis) |
C |
osteoarthritis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000076864 |
RAP1GAP |
rs9426676 |
0.0160 |
0.6904 |
0.0111 |
0.0144 |
1 |
Glutamatergic (Lake), exCA1 (Habib) |
C |
ovarian problem |
245,494 |
Roslin Institute |
30349118 |
2018 |
ENSG00000171791 |
BCL2 |
rs17676919 |
0.0770 |
0.4183 |
0.0322 |
0.0877 |
1 |
GABAergic (Lake) |
C |
psoriasis |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000197579 |
TOPORS |
rs11795343 |
0.9561 |
0.5938 |
0.5677 |
0.5677 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000185201 |
IFITM2 |
rs10751647 |
0.1129 |
1.0000 |
0.1129 |
0.1129 |
1 |
END (Habib) |
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000108774 |
RAB5C |
rs731151 |
0.1535 |
0.4840 |
0.0743 |
0.1128 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000169169 |
CPT1C |
rs1075453 |
0.0289 |
0.9929 |
0.0287 |
0.0287 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000198917 |
C9orf114 |
rs112086410 |
0.0310 |
0.8921 |
0.0276 |
0.0501 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000146830 |
GIGYF1 |
rs221781 |
0.0802 |
0.2183 |
0.0175 |
0.0683 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000142102 |
ATHL1 |
rs7937786 |
0.2440 |
0.0707 |
0.0172 |
0.0191 |
4 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000130518 |
KIAA1683 |
rs7247222 |
0.0818 |
0.2068 |
0.0169 |
0.0343 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000168071 |
CCDC88B |
rs479552 |
0.0155 |
0.9962 |
0.0154 |
0.0154 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000130522 |
JUND |
rs12973608 |
0.0857 |
0.1568 |
0.0134 |
0.0559 |
1 |
NSC (Habib) |
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000160447 |
PKN3 |
rs13289095 |
0.0348 |
0.3477 |
0.0121 |
0.0279 |
1 |
|
C |
thyroid problem (not cancer) |
452,264 |
Roslin Institute |
30349118 |
2018 |
ENSG00000026297 |
RNASET2 |
rs2757039 |
0.0384 |
0.3117 |
0.0120 |
0.0187 |
1 |
Microglia (Habib) |